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Abstract   
Studies have found a link between cardiovascular risk factors (CVRFs) and Alzheimer’s 
disease however; the mechanism by which CVRFs increase the risk of cognitive decline is 
not fully understood. The current study attempts to improve CVRFs in order to enhance 
cognition in older adults. Primary outcomes include ambulatory and clinical resting systolic 
and diastolic blood pressure (SBP; DBP).  In total, 89 community-dwelling older adults with 
subjective cognitive complaints were randomized to either a multiple-modality mind-motor 
(M4) exercise or a multiple-modality (M2) exercise only. Significance was found in 
nighttime peak SBP (6.55 mmHg, p=.04) between groups, with a decrease in M2 compared 
to M4. Clinical resting SBP also decreased (6.99 mmHg, p=.03) between groups, whereby 
M4 further decreased compared to M2. Both M2 and M4 have some influence on ambulatory 
and clinical resting BP however, further research is required to elicit the effects of M4 and 
M2 on CVRFs.  
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Chapter 1 : Introduction 
Brief Introduction to Thesis 
Cognition is referred to as the mental act or process by which knowledge is developed 
through the incorporation of perception, intuition, reasoning and judgement. According to 
Hendrie et al., cognitive health, much like physical health (i.e. vascular health), can be 
viewed along a continuum; ranging from optimal functioning to mild cognitive 
impairment to severe dementia such as Alzheimer’s disease1. As the population continues 
to age, the prevalence of age-related diseases such as Cardiovascular Disease (CVD) and 
dementia are increasing2. There is growing support associated with the significance of 
cardiovascular risk factors (CVRFs) and the advancement of dementia, including 
Alzheimer’s disease (AD)2.  
Increased blood pressure, along with the associated stiffening of arteries are some CVRFs 
that reduce cerebrovascular vasoreactivity and cerebral blood flow and render older 
adults to a greater risk of decreased blood flow in the brain3,4, and poorer cognitive 
function. Sustained hypertension is also coupled with the formation of white matter 
lesions5,6, hippocampal atrophy7, the occurrence of neurotropic markers of AD8 and 
clinical dementia8,9.  Furthermore, age and sex also impact CV health. The Framingham 
Heart Study, a longitudinal study which followed participants for 40 years found a 
continuous increase in systolic blood pressure (SBP) between the ages of 30 and 84 
years. Diastolic blood pressure (DBP) has greater variability in ageing with an increase 
up to the late 50’s and then a decrease from the age 60 to 84 years of age. This variance 
in BP creates a steep incline in pulse pressure with ageing10,11. Sex, specifically females 
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have a greater susceptibility to CVD in ageing12. Ford et al., explained the longer life 
expectancy within females comprises a greater fraction of the older adult population 
where CVD is most prevalent12. Therefore, both age and sex may influence CV health 
and lifestyle modifications should be done in order to control the risk of CVD and its 
associated risk factors.  
Aerobic exercise (AE) has shown to overturn elevated central arterial stiffness in healthy 
middle-aged and older subjects9 by enhancing blood flow in the brain’s pre-frontal cortex, 
while resistance training can augment hippocampal volume and circulating neural growth 
factors, which are all proposed mechanisms that protect or improve cognition as we 
age13. For instance, a review by Lange-Asschenfeldt & Kojda concluded that exercise 
training reduces vascular oxidative stress and improves vascular endothelial function, 
both of which promote greater arterial compliance and cerebral blood flow14. Since 
decreased arterial compliance has been related to increased cerebrovascular resistance15, 
and reduced cerebrovascular resistance has been observed during antihypertensive 
therapy16, the use of AE to reverse hypertension (i.e., reduced arterial stiffness) may be a 
method to improve cognition in at-risk patients for cognitive decline who have CVD.  
Observational studies have revealed physical activity as a primary method to improve 
vascular health, cognitive function and delay or prevent the onset of dementia17-21. It has 
also been suggested that a multiple modality (M2), (combined AE, resistance and 
stretching exercises) have optimal effect on cognition when compared to providing each 
type independent of one another22-24. In addition, cognitive training (CT) has also shown 
improved cognition, which is gaining more attention. Observational studies have found 
 3 
 
CT to be just as effective at improving cognition as administering AE for older adults at 
risk of cognitive decline25. The exploration of a collective physical and cognitive exercise 
program is critical for the advancement of understanding by which different domains of 
exercise can impart cognitive benefits in aging25. 
There are very few randomized controlled trials that have investigated the effects of 
modifying vascular risk factors on cognitive health and functioning in either healthy older 
adults, or those with a cognitive complaint, mild cognitive impairment (MCI), or 
dementia13 through the incorporation of CT. Therefore, a systematic review was 
conducted to establish the state of the literature available regarding the effects of CT with 
or without exercise on cardiovascular (CV) health in older adults and to see whether a 
specific program of CT and/or exercise warrants prescription for older adults at risk for 
future cognitive decline26 through the improvement of CVRFs. 
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Chapter 2: Systematic Review 
The effect of cognitive training (CT) on cardiovascular health in 
community-dwelling older adults: A systematic review 
Amanda M Deosaran1,2, Sanjit K Bhogal4 PhD,  Dawn P Gill2,3,4,7 PhD, Michael 
Gregory2,6, Robert J Petrella1,2,6,7 MD, PhD 
1School of Kinesiology, Faculty of Health Sciences, Western University, London, Ontario, Canada; 
2Lawson Health Research Institute, London, Ontario, Canada; 3School of Health Studies, Western 
University, London, Ontario, Canada; 4Department of Epidemiology, University of Washington, Seattle, 
Washington, United States; 5Department of Surgery, St. Michael’s Hospital, Toronto, Ontario, Canada; 
6Department of Health & Rehabilitation Sciences, Faculty of Health Sciences, University of Western 
Ontario, Canada; 7Department of Family Medicine, Schulich School of Medicine and Dentistry, Western 
University , London, Ontario, Canada  
KEY WORDS: cognitive training, vascular risk factors, aging, community-dwelling 
adults, systematic review  
BACKGROUND: Exercise training may mitigate the impact of vascular risk factors on 
cognitive function in older adults; however, whether cognitive training can modify 
vascular risk factors is unclear.  
OBJECTIVE: To systematically review the impact of cognitive training on vascular 
health in community-dwelling older adults. 
Data Sources: A systematic review of English articles from year 2000 and onwards using 
CINAHL, Pub Med, PsycINFO, Scopus, EMBASE databases.  
STUDY SELECTION: Only clinical trials (RCTs or nonrandomized studies) that 
assessed the effects of CT, administered with or without an exercise or physical activity 
component. Studies were eligible for inclusion if they studied the effectiveness of CT 
among healthy or cognitively impaired community-dwelling older adults aged 55 years or 
older.  
DATA EXTRACTION: One author independently selected the trials, and two authors 
assessed trial quality and extracted necessary data.   
OUTCOMES: The primary outcome of interest was: systolic blood pressure. Secondary 
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outcomes included: diastolic blood pressure, lipids, inflammatory markers (i.e. Brain 
derived neurotrophic factor, BDNF; Insulin-like growth factor 1, IGF-1), vascular 
mechanics (i.e. arterial stiffness, intima-media thickness, dispensability), heart rate 
variability and maximum oxygen uptake (Vo2max)] or any other vascular risk factors 
associated with dementia (i.e. cerebral blood flow).  
RESULTS: Four articles were included for qualitative synthesis. Each study reported on 
at least one vascular outcome. One study showed a significant increase in regional 
cerebral blood flow (43.6 to 59.2 ml/100·g tissue/min) and another article demonstrated a 
significant improvement in clinical systolic (140.06 to 128.97 mmHg) and diastolic 
(76.41 to 73.41 mmHg) blood pressure. However, the remaining two articles that looked 
at VO2max, revealed controversial results. 
CONCLUSIONS Although limited studies have shown noteworthy improvement 
following CT in some areas of vascular health (i.e. cerebral blood flow, blood pressure 
and VO2max), more research is needed to confirm and include a greater number of 
outcomes in cardiovascular health.   
 
Corresponding Author 
Robert J Petrella, MD, PhD 
Western Centre for Public Health and Family Medicine (PHFM) 
1465 Richmond Street, 2nd Floor 
Western University 
London, ON, N2G 2M1 
petrella@uwo.ca 
 
INTRODUCTION 
The incidence of age-related diseases such as cardiovascular disease (CVD) and dementia 
are expected to significantly increase as the population ages27.  Canada's aging 
population, combined with alarming trends in cardiovascular risk factors (CVRFs) such 
as obesity, physical inactivity, hypertension, and diabetes are expected to further increase 
the risk of dementia including Alzheimer’s disease (AD)27-29. 
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 The World Health Organization (WHO) has estimated by 2030, more than 23 million 
people will die annually from CVD30. In 2008, nearly 14 million deaths occurred after the 
age of 60 and more than 3 million deaths occurred before the age of 6030.  The WHO has 
also projected that the total number of people with dementia will almost double every 20 
years to 65.7 million in 2030 and 115.4 million by 205031.  Despite the increasing 
prevalence of dementia in the older adult population, there is currently no effective 
treatment.  Hence, some studies have investigated targeting modifiable CVRFs to 
mitigate cognitive decline31. 
The brain depends on a continuous supply of regulated blood flow, therefore, cognitive 
health and function is partially reliant upon cardiovascular (CV) dynamics32. Many 
studies have focussed on the effect of blood pressure, specifically systolic blood pressure 
(SBP) and its influence on cognition33-35. Cross-sectional research studies have found an 
association between hypertension (SBP >140 mm Hg; DBP > 90 mm Hg) and cognitive 
decline in adults aged 55 years or more in various ethnicities33-35.  Similarly, longitudinal 
studies observed comparable results, whereby adults aged 60 years and older who were 
hypertensive or had continually high SBP in midlife, had a higher risk of AD occurrence 
in late life or suffered from significant cognitive decline36,37. See Table 1 for blood 
pressure (BP) studies on cognition.  
Furthermore, other CVRFs including inflammatory marker variability, decreased total 
serum cholesterol, lowered high density lipoprotein (HDL), reduced heart rate variability 
(HRV) and increased arterial stiffness were all associated with cognitive decline38-40. See 
Table 2 for other CVRFs studies on cognition 
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Table 1: BP Studies on Cognition 
Abbreviations: BP, blood pressure; SBP, systolic blood pressure; AD, Alzheimer’s Disease;  
 mm Hg, millimeters of mercury 
 
 
 
Cross sectional BP Studies 
Author Study Population CVRF Main Results 
Kuo et al.33 aged ≥65 years old, 
healthy 
SBP SBP >145 mm Hg linked to impaired 
executive function 
Steward et 
al.34 
British African, 55-75 
years old 
BP Clinically diagnosed hypertension and 
cognitive impairment are linked 
Andre-
Petersson et 
al.35 
Swedish Men, aged 
68+ years old 
BP BP ≥180/110 mm Hg was related to 
poorer performance on the 
neuropsychological test battery 
Longitudinal BP studies 
Wu et al.36 Chinese, ≥65 years 
old 
21 year 
follow-up 
BP 
Hypertension (160/95 mm Hg) in 
midlife was related to a higher risk of 
AD prevalence in late-life11 
Waldstein et 
al.37 
Baltimore, 60-96 
years old 
11 year 
follow-up 
SBP 
SBP (continuous variable) was 
associated with decreased cognitive 
performance, and greater cognitive 
decline when asked to complete a 
series of neuropsychological tests12. 
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Table 2: Other CVRFs Studies on Cognition 
Other study interventions have improved CVRFs, which subsequently slowed cognitive 
decline. Burns et al. conducted a study of brain atrophy and cardiorespiratory fitness, 
specifically VO2peaks (the highest value of volume of oxygen attained during a 
particular fitness test) in subjects without dementia and subjects with early onset of AD. 
Other CVRFs studies 
Author Study Population CVRF Main Result(s) 
Metti et al.38 Non-demented, 
70-79 years old 
Inflammatory 
marker: C-
reactive protein 
(CRP) over 10 
years 
CRP variability reflected poor 
control of, or more, pronounced 
changes in vascular or metabolic 
disease over time  leading to an 
associative cognitive decline 
Kim et al.39 and 
Atzmon et al.40 
Non-demented, 
elderly  
Total serum 
cholesterol, 
high density 
lipoprotein 
(HDL) 
Lower total serum cholesterol and 
lower high density lipoprotein 
(HDL) were connected with 
reduced cognitive ability 
Al Hazzouri and 
Yaffe41 
Mexican-
American, 
community-
dwelling older 
adults 
Heart rate 
variability 
(HRV) 
Found an association between 
reduced HRV and poorer cognitive 
function 
Al Hazzouri and  
Yaffe42 
Older adults Arterial 
stiffness 
Increase in arterial stiffness was 
coupled with lower cognitive 
performance. This was observed on 
measures of global cognition and 
over several domains of cognition 
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They found an increase in VO2peaks were associated with a decrease in brain atrophy in 
non-demented elderly subjects43.    
The Rotterdam study also observed a higher cerebral blood flow (CBF) velocity and its 
association with a lower likelihood of getting dementia44. Lastly, Fukuhara and 
colleagues suggested that arterial stiffness could predict cognitive function in the elderly, 
specifically pulse wave velocity (PWV), which was independently associated with Mini-
Mental State Examination (MMSE) scores45. Increasing evidence suggests the 
contribution of CVRFs to cognitive health and therefore, it is imperative to find ways to 
mediate such risk factors due to their significant role in cognition32.  
Studies that utilized exercise interventions have found beneficial effects on CV health46. 
Exercise is described as a method of physical activity that is a structured routine extended 
over a period of time with intentions of enhancing fitness, function or health47. Exercise 
training can be administered in various forms such as dynamic/isometric resistance or 
strength training which improve muscle mass; aerobic exercise (AE) training whereby it 
decreases arterial stiffness; flexibility and balance training which aid in posture; and 
mobility training which decreases the risk of falls46. Many studies have used exercise, 
specifically AE to improve CV health in older adults. One study found AE preserved 
endothelial function with aging and directly induced arterial protection. Seals and Adolph 
concluded that AE should be used as a “first line” strategy for prevention and treatment 
of arterial health48.  Furthermore, a study by Ten Brinke et al., observed after six months 
of AE training, a significant enhancement in hippocampal volume in older women with 
possible mild cognitive impairment (MCI)49. Although studies have looked at exercise to 
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improve CV health, it is still uncertain whether exercise in its entirety, is the most 
beneficial method for improving CV health.  
Cognitive training (CT) has been considered another form of exercise, specific for the 
brain, which acts as a protective factor as we age and may be a possible prevention 
measure for cognitive impairment50. For the objective of this systematic review, CT are 
defined as “structured, repetitive practices on tasks with a distinctive problem, using 
standardized tasks targeting specific cognitive domains and/or teaching strategies and 
skills in order to optimize cognition and functioning”51,52. Cognitive training 
interventions incorporate training of executive function networks of the brain to segregate 
attention and co-ordinate actions more efficiently and effectively53. Research suggests 
that executive control processes and their underlying brain regions are plastic and can be 
modified by CT54. Examples of CT include non-computer based training programs such 
as a study done by Oshugi et al., who compared a single task (either doing calculations or 
performing step climbing) and dual task (performing both single tasks simultaneously)55. 
Another study used a novel square stepping exercise, whereby participants had to 
remember a demonstration of a stepping pattern and then perform it on a mat partitioned 
by squares56. Computer based CT are also used, such as variable priority training 
developed by Kramer et al.57, and examined by MacKay-Brandt58. This task involves 
performing two concurrent tasks on a computer. For example, one version of this task 
required “cutting” a flower image at random locations on the monitor (cutting requires 
the participant to use the mouse to position an image of scissors over the flower and 
clicking). Instantaneously, single digits bounded in a box were shown serially in the 
middle of the monitor whereby participants had to press a number key to indicate the 
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correct sum. Other CT have involved music or a musical instrument59, choreographed 
dance60 or various dual-tasks such as walking on a treadmill while completing another 
task23.  
Furthermore, studies have also compared CT and AE to examine which method was more 
beneficial. Klusman and colleagues recognized objective measures of memory and 
executive function (EF) (Trail Making Test B divided by A) were preserved or enhanced 
in older women with mild cognitive impairment (MCI; MMSE ≥ 20) after receiving 6 
months of either CT or AE. Interestingly, cognitive function improved to a similar extent 
in both individuals receiving CT or AE61.  This suggests CT may be a possible 
intervention to reduce the risk of cognitive decline analogous to AE in older adults with 
MCI, and that CT may pass on similar effects to individuals who are free of MCI. 
It is uncertain whether cognitive training will instil similar effects on CV health despite 
the interrelation between cognitive function and CV health.  The exploration of CT with 
or without an exercise program on vascular health is still critical for the advancement of 
understanding by which CT, as a type of exercise, can affect CV health in aging. This 
systematic review aims to: 1) examine the effects of CT, with and without exercise, on 
SBP in community-dwelling older adults with and without cognitive impairment but no 
dementia, and 2) identify whether any other CVRFs are improved by CT.  
The research question for this systematic review was developed using the PICO: 
Population, Intervention, Comparison and Outcome(s) 
(http://learntech.physiol.ox.ac.uk/cochrane_tutorial/), framework. Xiaoili and colleagues 
investigated the validity and suitability of the PICO framework and confirmed its 
appropriateness for structuring clinical questions62.  Our review question is stated as: 
 12 
 
Among community-dwelling adults (aged 55 years and older) with and without cognitive 
impairment, do those who receive CT alone or in combination with any form of exercise 
have improved vascular health [such as lower blood pressure (systolic and diastolic), 
higher maximum oxygen uptake (Vo2max), or improved lipids, inflammatory markers 
(i.e., BDNP, IGF-1)], vascular mechanics (i.e., arterial stiffness, intima-media thickness 
(IMT), dispensability), and heart rate variability, compared to those who received an 
alternative therapy. 
METHODS  
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines and statement were used as a protocol for this review63. Registration of this 
systematic review was completed through Prospero, an international prospective register 
for systematic reviews (registration #CRD42014013876).  
Eligibility 
Types of Studies 
Eligibility for inclusion consisted of trials, irrespective of randomization, which evaluated 
CT against an appropriate comparator intervention that did not include a CT intervention. 
Studies used either a randomized controlled trial (RCT) or nonrandomized intervention 
trial.  The article had to address any confounding factors (i.e. race/ethnicity/culture, 
gender, education, age, CVRFs) and compare study participants to at least one of the 
possible confounding factors.  
Types of Participants  
Community-dwelling adult population, aged 55 years or older were considered. 
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Participants were excluded if they (1) self-reported (based on diagnosis by a physician) or 
suspected to have dementia based on study specific assessments [(i.e. neurological 
examination such as the Mini-mental State Examination (MMSE), Montreal Cognitive 
Assessment (MoCA ) or other assessment tools],  (2) presented with other neurological or 
psychiatric conditions, including, Parkinson’s Disease; Bipolar disease, Schizophrenia, 
ADHD, Bipolar disorder, cerebral palsy, Horton disease, Downs Syndrome, Epilepsy, 
Fibromyalgia, Huntington’s disease, Intracranial Hypertension, Neurofibromatosis, Tay-
Sachs disease, Tourette Syndrome, Traumatic brain injury, or (3) who have not 
experienced a major cardiovascular event in last 2 years, were included.    
 
Types of Intervention 
The intervention of interest was CT. Both computer- and non-computer-based CT 
interventions were considered.  The CT intervention could occur in isolation or in 
combination with exercise.  The following exercise components were accepted:  (1)  
Aerobic exercises (water-based exercises, yard work, dancing, biking, climbing stairs, 
field sports, basketball, tennis, hockey, football, aerobics); (2) Strength exercises (weight 
lifting, resistance training, muscle training); (3) Balance exercises (martial arts, tai-chi, 
qigong); (4) Flexibility exercises (yoga, upper and lower body stretches); and (5) Other 
type of exercise deemed appropriate by the study authors (i.e. Wii-based exercise 
program60, coordination training64, functional tasks exercises65).  Cognitive training 
interventions that also included diet or pharmacological components were excluded. The 
comparator group had to be an alternative therapy that excluded CT, such as standard or 
usual care, active control (non-CT group), or allocated to a wait-list group.  
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Outcome 
Main Outcome 
The primary outcome of interest was ambulatory SBP (measured in mm Hg).  
Ambulatory blood pressure gives a valuable sense of how one’s blood pressure fluctuates 
in regular activities performed throughout the day. Blood Pressure patterns over 24 hours 
could also have inferences about cognitive function, however not many studies have 
focussed on ambulatory BP58.  The US Preventative Services Task Force is also 
considering having an ambulatory blood pressure monitor (ABPM) as an inclusion factor 
for the screening and diagnosis of hypertension66. Therefore, if ABPM’s become widely 
accepted, comprehending its interaction in addition to age-related outcomes such as 
cognitive function will be beneficial for the population at large67.  
Secondary Outcomes 
Other CV outcomes that were considered included: (1) ambulatory DBP, (2) carotid 
arterial stiffness, (3) other arterial stiffness (not carotid), (4) carotid intima-media 
thickness, (5) intima-media thickness (not carotid), (6) distensibility, (7) VO2max, (8) 
heart rate variability, (9) lipids (i.e. triglycerides, steroids, phospholipids), (10) 
inflammatory markers [(i.e. BDNP, endothelial markers, adhesion molecules, IGF-1, 
cytokines (i.e. IL-1, IL-6, TNF-α), acute-phase reactants (i.e. fibrinogen, SAA, CRP), 
white blood cell count)], and (11) other CV outcomes (i.e. cerebral blood flow, pulse 
pressure, pulse wave velocity).  
Sociodemographic Factors 
The following sociodemographic factors were considered for influences associated with 
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CV health. Place of residence was categorized by geographical location, and classified by 
urban or rural. Race was defined by the following categories: Caucasian, African 
American, Asian, or other. Sex was categorized by male or female. Level of education 
was defined as: primary education, secondary education, post-secondary (non-trade), 
post-secondary (trades), graduate or other. Age was documented by mean, mean 
interquartile range and/or by categories: 55-64, 65-74, 75-84 and 85+ years.  
Information Sources 
Studies were identified by searching electronic databases, reviewing reference lists of 
eligible articles and consulting with experts in the field. The search strategy was 
developed with the help of experts in the field and aid of an experienced librarian from 
the Taylor Library, Western University. Restrictions were implemented for English 
language only and published in 2000 onwards. A limit on date was set due to the rarity of 
research in CT prior to 2000. The following databases were searched:  Pubmed, 
CINAHL, EMBASE, Scopus, PsycINFO.  We also searched secondary sources, 
including, the Cochrane library, Prospero database, and Google Scholar. Furthermore, we 
manually searched the reference lists of all included articles and contacted one author to 
acquire a full text version of their study. The final search was completed in July 2014 
with an updated search performed at the beginning of January 2015.  
Search Strategy 
The following terms were used in the search strategy (note: each term was searched 
separately and then combined with ‘OR’):  
[(brain training” OR “memory training” OR dual tasking OR dual-task OR “mental 
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activity” OR “mental training” OR brain exercise OR brain exercises OR “cognitive 
training” OR "computer based cognitive training" OR “computerized brain training” OR 
psychoeducation OR square stepping exercise OR neuropsychological performance)  
AND  
(vascular OR blood pressure OR artery OR arteries OR cerebrovascular OR 
neurovascular OR cardiovascular OR “blood flow” OR “arterial compliance” OR blood 
vessel OR blood vessels OR “carotid artery” OR VO2max OR “arterial stiffness” OR 
blood flow velocity OR “heart rate” OR “pulse pressure” OR “aerobic fitness” OR 
“vascular mechanics” OR “peripheral circulation” OR vascular stiffness)  
AND  
[(“older adult” OR “older adults” OR seniors OR 55+ OR mild cognitive complaint OR 
cognitive complaint OR mild cognitive complaints OR cognitive complaints, OR senior 
OR aged OR geriatrics)] 
Study Selection 
One researcher independently reviewed the title, abstract or description of all trials 
identified by the literature search.  For level 1 screening, the eligibility criteria were kept 
broad, as outcomes are often poorly reported in titles and abstracts. Studies that aimed to 
conduct CT in individuals over the age of 55 years were selected. The eligibility criteria 
were stricter for full-text review and the type of CT intervention, outcomes reported, and 
study designs were scrutinized to determine if they met the inclusion criteria.  
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Data Extraction 
Two independent researchers extracted data from included studies using standardized 
extraction forms.  Discrepancies were resolved by discussion until a consensus was 
reached.   Data items collected included: study characteristics (i.e. type of intervention, 
location, length of study, recruitment), subject characteristics (i.e. age, gender, race, 
education, eligibility, inclusion and exclusion criteria), primary and secondary outcome 
results (if CV variables were present), details of the CT intervention and comparator 
group(s), statistical analysis (i.e. statistics used, power calculation), withdrawal and lost 
to follow-up reasons.  The presence or absence of the following comorbidities were also 
documented: hypertension, dyslipidemia, diabetes, coronary artery disease, 
cerebrovascular diseases, transient cerebral ischemic attack, coronary heart disease, 
severe orthopedic limitations, and depression. 
Quality Assessment 
In order to determine the validity of eligible RCTs, two researchers independently 
assessed the risk of bias in all of the included studies.  The PEDro scale was used to 
assess study quality and validity of the articles (pedro.org.au). The PEDro scale is an 
accepted and reliable tool, determined to have sufficient reliability for its use in 
systematic reviews of physical therapy RCTs61. The PEDro scale consists of an 11-item 
scale with the final PEDro score is based on a maximum score of 10; Item 1, which 
relates to external validity, is excluded from the final score. See Appendix A (Table 1) 
for details of each item and scoring.  
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Data Synthesis and Analysis 
Data synthesis was conducted from a description of studies and qualitative synthesis of 
findings; therefore, heterogeneity via a statistical approach was not conducted. 
Altogether, studies used various forms of CT, length of intervention and outcomes; of 
which only 2 had the same CV outcome; determined a priori that three studies would 
need to assess the same outcome in order to conduct a meta-analysis. 
RESULTS 
Study Selection 
The initial literature search identified 640 titles and abstracts, of which 73 were removed 
for duplicate citations. Of the remaining 567, 556 (98.1%) were excluded because the 
article: (1) did not explore CT in the context of vascular outcomes (97.4%); (2) did not 
include any form of CT (88.1%); (3) did not compare CT to any alternative therapy 
(87.1%); (4) did not screen out patients for dementia (75.2%); (5) did not include an 
appropriate intervention and comparator (55.4%); (6) did not compare participants to at 
least one confounding factor outlined (43.9%); and (7) included patients under the age of 
55 years (26.3%). Of the remaining 11 articles, 7 (1.4%) of them were excluded because 
the article: (1) was a protocol study (.35%); (2) was still on-going (.35%); and (3) did not 
aim to explore CT in the context of managing vascular health (.70%). In total, four 
studies were included in the systematic review, see Figure 1 for the CONSORT diagram.  
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638 citations identified 
through database 
searching  
73 duplicate citations 
removed 
2 additional citations 
identified through other 
sources 
 567 citation screen  
(by title and 
abstract)  
11 full-text articles 
assessed for eligibility  
 4 studies included in 
qualitative synthesis   
556 (98.1%) citations excluded 
  98.6% did not aim to explore cognitive 
training in the context of vascular health 
 55.4%  did not include an appropriate 
intervention vs. control program 
 26.3%  patients were under 55 years of age 
  75.2% patients were not screened out for 
dementia 
  88.1% did not include any form of 
cognitive training  
  87.1% did not compare cognitive training 
to any alternative therapy 
 43.9% did not compare participants to at 
least one confounding factor outlined  
 7 (1.4 %) citations excluded 
  .35% were still on-going studies; results 
were not provided  
  .352% were protocol studies 
 .70%  did not aim to explore cognitive 
training in the context of managing 
vascular health 
Figure 1: CONSORT Diagram for Systematic Review 
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Study Design and Study Quality 
Study characteristics of the four included studies are presented in Table 3. All four 
studies were published in English, with all but one study having an 8 week intervention 
period. They all had a parallel group RCT design, and assessed for dementia using a 
diagnostic tool or by subjective report.  They all scored a 6, 8 or 9 out of a perfect score 
of 10 on the PEDro scale of quality assessment, a valid measure of the methodological 
quality in clinical trials70.  
All four studies received a point on the PEDro scale for: (1) specifying their eligibility 
criteria; (2) having similar groups at baseline regarding the most important predictive 
markers; (3) measuring at least one key outcome of which was obtained from more than 
85% of the subjects initial allocation to groups; (4) all subjects received the treatment or 
control condition as allocated or, where this was not the case, data for at least one key 
outcome was analysed by “intention to treat,” and (5) reporting the results of between-
group statistical comparisons for at least one key outcome. All but one study provided 
both point estimates (i.e. means) and variability measures (i.e. standard deviations) for at 
least one key outcome.  
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Table 3: Study Characteristic Details of Accepted Articles 
Author, 
Year 
Study 
Design 
Dementia 
Diagnostic 
Tool  
Type of CT Training 
Length 
Comparator 
 Group 
Covariates 
Mozolic 
et al., 
201068 
aRCT MMSE score 
within 2.5 
SD of the 
mean for 
their age and 
educational 
level 
Non-computerized 
Training, targeting 
attention and 
distractibility 
projected on a 
movie screen 
8 weeks Went to lab and 
listened to 
lectures/educati
onal program 
----- 
Shimzu 
et al., 
201359 
bRCT Excluded 
serious 
medical 
conditions 
that may 
interfere 
with 
participation 
in study 
(subjective 
report) 
Movement music 
therapy (MMT) 
with Naruko 
Clapper 
8 weeks Exercise with 
counting and 
no music 
Age, 
weight 
Fabre et 
al., 
200222 
 
aRCT BEC score 
of 94.0 (.97) 
 
Israel’s Method 8 
Themes:  
 perceptive 
activities 
 attention 
 intellectual 
structuration 
 association and 
imagination 
 language 
 spatial marks 
 temporal marks 
 associated 
recruiting 
2 
months 
Leisure 
activities 
i.e. painting 
and choral 
singing 
 
Age, body 
mass, 
height 
Linde et 
al., 
201469 
bRCT Subjective 
report 
Editing worksheets, 
selected from CT 
manual developed 
& evaluated by 
Oswald et al. 
16 
weeks  
Inactive 
waiting control; 
Standard or 
usual care 
CVD 
regimen 
Abbreviations: MMSE, Mini-Mental State Examination; CVD, Cardiovascular Disease; RCT, Randomized 
controlled trial. aRCT: Parallel; bRCT: Factorial 
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However, none of the studies received a point for blinding their therapists who 
administered the therapy.  Merely two studies received a point for blinding their subjects 
(to group allocation only). Firstly, Linde and colleagues69 had the only study to receive a 
point for having concealment of allocation, thereby avoiding systematic biases. Secondly, 
Linde and colleagues blinded their assessors who measured at least one key outcome; 
therefore giving their study the highest score on the PEDro scale of 9 out of 10, see Table 
4.  
Table 4: PEDro Scale 
Item Scale Mozolic et 
al., 201068 
Shimzu et 
al., 201359 
Fabre et 
al., 
200222 
Linde et 
al., 
201469 
Randomized  Yes Yes Yes Yes 
Concealed Allocation No No No Yes 
Baseline Similarity Yes Yes Yes Yes 
Subjects Blinded Yes Yes No No 
Therapists Blinded No No No No 
Assessors Blinded No  Yes No Yes 
Outcome from >85% of 
Subjects 
Yes Yes Yes Yes 
Intention-to-treat Yes Yes Yes Yes 
Between-group Statistic Yes Yes Yes Yes 
Point & Variable Measures No Yes Yes Yes 
Total Score 6 8 6 9 
1 point given for yes, 0 points for no 
Participants 
The included studies contained 226 participants. The mean age of participants in the 
control group across all studies ranged between 65-77 years old. Similarly, the 
intervention groups had the same mean age range across all studies. Participant 
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withdrawals from studies included: (1) scheduling restraints or MRI incompatibility; (2) 
small amount of male enrollment; (3) health complaints; or (4) in some cases, were not 
reported. All studies included community-dwelling older adults age 55 years or older 
who were deemed healthy or cognitively impaired, no dementia through a diagnostic 
assessment or subjective report. See Table 5 for subject characteristics details. 
Cognitive Training 
All four studies differed on their intervention. Mozolic and colleagues conducted an 8 
week intervention using a non-computerized training program that targeted attention and 
distractibility68.  Participants had to supress irrelevant distractors (i.e. short video clips for 
visual distraction or sound clips for auditory distraction) of people, places, and events 
while completing tasks requiring detection, classification and/or sequencing visual or 
auditory presentations of letters, words, and numbers (2-5 mins/task). An active control 
group was required to attend lab and listen to educational programs68.   
On the contrary, Shimzu et al., also conducted an 8 week intervention but used movement 
music therapy (MMT) with a Naruko Clapper59. The Naruko is a musical instrument 
made of an uncomplicated clapper mechanism. Participants were instructed to clasp the 
Naruko and shake it, generating a clapping sound while coordinating with background 
music.  
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Table 5: Subject Characteristic Details 
C: Control; I: Intervention. cCS: USA; dCS: Japan eCS: France; fCS: Germany 
The clapper utilizes whole body movement, and is a beneficial exercise for flexibility of 
joints and strengthening of limbs. The intervention included 5 steps: (1) verbal greetings, 
(2) warm-up, (3) light exercises, (4) main exercise and (5) relaxation. The control group 
performed the same exercises as the intervention group however; subjects did not have 
music or operate the Naruko59.   
For 8 weeks, the Israel method which targets 8 themes of cognitive function was 
employed by Fabre and colleagues22. The session commenced with 15 minutes of 
Author, 
Year 
Study 
Site 
Total 
Eligible 
Total 
Female 
(%) 
Withdrawal 
Reasoning 
Total 
Analyze 
(C) 
Total  
Analyze  
(I) 
Mean ± 
SD Age  
(C) 
Mean ± 
SD Age  
(I) 
Mozolic 
et al., 
201068 
cCS 66 55.3 Scheduling 
constraints 
or MRI 
conflict 
25 23 69.4±2.4 69.3±3.2 
Shimzu 
et al., 
201359 
dCS 124 100 Males 
excluded 
due to small 
amount of 
males 
33 58 76.3±5.0 76.5±4.6 
Fabre et 
al., 
200222 
eCS 32 ----- ----- 8 24 65.7±1.5 65.9±1.4 
Linde et 
al., 
201469 
fCS 70 58.6 Logistic 
issues, 
health 
complaints, 
participation 
in other 
programs, 
dislikes 
intervention 
13 42 66.7±3.2 67.2±3.3 
 25 
 
explaining memory mechanisms followed by participants working according to the theme 
of the session. The 8 themes included: (1) perspective activities (sight and hearing) such 
as remembering details from pictures of people or objects and detecting a particular 
sound in an auditory text, (2) Attentional activities required reading different texts and 
summarizing the main idea, (3) intellectual structuration was stimulated by completing 
word beginnings, (4) association and imagination activities such as finding hidden objects 
in a picture or finding similar or differential areas in a picture of humans, animals or 
objects, (5) language activities had to retrieve opposite or complementary words, (6) 
spatial marked activities were stimulated by drawing the mirror image of different 
objects, (7) temporal marked activities required ordering in  chronological order the news 
events or personal recollections, and lastly (8) associated recruitment was stimulated by 
using personal dates (birthdays, anniversaries) to remember banking and social security 
numbers. On the contrary, the active control group was required to perform leisure 
activities22.  
Lastly, the longest intervention of 16 weeks was executed by Linde and colleagues69. 
Selected exercises from a CT manual developed by Oswald et al.24,71, were used. The 
primary focus of the CT intervention required subjects to edit worksheets either alone, 
with a partner or in a group. After a 5-minute short-term memory warm-up training, 25-
minutes were allocated to practicing:  short-term memory, visuospatial skills, information 
processing speed, concentration, and logical reasoning. At the end of each session, two 
additional exercises were given as homework. This was the only study that had an 
inactive, standard care control group69.  
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Risk of Bias Across Studies 
In order to exclude participants with dementia, various screening tools were used across 
the four studies. Mozolic and colleagues used the Mini-mental state examination 
(MMSE)68, a valid and reliable 30-point questionnaire which is commonly used in 
clinical and research settings to measure cognitive impairment72. Two studies excluded 
for dementia/serious medical conditions by subjective indication from the 
participants59,69. The BEC 96 questionnaire was performed by Fabre and colleagues22. A 
semantic and fluency task administered to participants to measure cognitive function and 
detect cognitive issues66. All but one study had an active control group in their 
study68,59,22.  Generally the mean age of participants differed across all four studies. Two 
of the studies had a mean age of mid 60’s22,69, whereas the remaining two studies had a 
much older mean age of late 70’s68,59.  
Outcome Measures and Intervention Effects 
Cerebral Blood Flow (CBF) 
Whole brain CBF was assessed in only one study68. However, due to insignificant 
findings in whole brain CBF, regional blood flow was examined and a significant finding 
in the right inferior frontal cortex (RIFC) and the mean group difference from pre-post 
was found. Right inferior frontal cortex was observed following CT that involved a non-
computerized training program targeting attention and distractibility projected on a movie 
screen. A significant increase (p<.05) of 15.6 ml/100·g/min (43.6 to 59.2 ml/100·g/min) 
for the intervention group in RIFC was found. However, the control group, who listened 
to educational programs in the lab, had a negative difference of 3.9 ml/100·g/min (58.1 to 
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54.2 ml/100·g/min). Therefore, CT indicated a beneficial effect of the intervention 
compared to the control group. 
Clinical Systolic and Diastolic Blood Pressure (cSBP and cDBP)  
Clinical SBP and DBP were assessed by Shimzu and colleagues59 after completing 8 
weeks of training with (intervention group) or without (control group) the Naruko clapper 
and music. The mean group difference from pre-post is presented. They found a 
significant decrease in SBP of 8.48 mm Hg (134.86±19.40 to 126.38±15.64 mm Hg; 
p=.004) in the intervention group and no change in the control group with a difference 
between groups pre-post of p=.109. DBP had no change in intervention, control or 
difference between groups.  
Maximum Volume of Oxygen Consumption (VO2max)  
Two studies examined changes in VO2max22,69.  The first study was done by Fabre and 
colleagues who had their participants complete the Israel method of eight themes22. Three 
different intervention groups were observed: (1) AE training, (2) CT, and (3) combined 
AE and CT and were compared to a control group that completed leisure activities (i.e. 
painting, singing etc.). A significant increase in VO2max was found in two of the three 
intervention groups. The AE training only group had increased the most out of all the 
intervention and control groups , with a difference of 280 ml·min-1 (1350±510 to 
1630±146 ml·min-1; p<.05). The combined intervention group had an increase of 115 
ml·min-1 (1510±109 to 1625 ml·min-1±217 ml·min-1; p<.05). However, the mental 
training only group decreased by 69 ml·min1 (1060±116 to 999±118 ml·min-1; p>.05). On 
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the contrary, the control group had a very slight increase in VO2max of 11 ml·min-1 
(1256±100 to 1265±115 ml·min-1; p>.05).  
The second study was by Linde and colleagues69. They observed VO2max before and 
after 4 months of editing worksheets, selected from a CT manual developed and 
evaluated by Oswald et al24,71. Similar to the study by Fabre and colleagues, 3 different 
intervention groups were used: (1) physical training, (2) CT, and (3) combined physical 
training and CT and were compared to an inactive waiting/standard or usual care control 
group. A significant increase in the physical training only group of 2.69 ml·min-1·kg-1 
(25.19±8.44 to 27.88±6.25 ml·min-1·kg-1; p<.05) was observed. In the CT only group, 
there was a clinically significant increase of 2.53 ml·min-1·kg-1 (25.41±7.73 to 
27.94±8.30 ml·min-1·kg-1; p<.10).  
Contrary to the findings of Fabre and colleagues, the combined intervention group was 
the most successful with an increase of 4.52 ml·min-1·kg-1 (24.1±9.97 to 28.86±8.72 
ml·min-1·kg-1; p<.01). Furthermore, in the control group, the two studies also differed. 
The control group significantly increased the most by 5.13 ml·min-1·kg-1 (23.90±8.34 to 
29.03±7.53 ml·min-1·kg-1; p<.001) compared to any of the intervention groups69. See 
Tables 6 and 7 for control and intervention group results. 
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Table 6: Control Group Results 
Author, Year Control 
Group 
CV 
Outcome 
Baseline Follow-Up P-
Value 
   N Mean SD Time N Mean SD  
Mozolic  
et al., 201068 
 CBF-
RIPC 
(ml/100· 
g/min) 
25 58.1 ----- 8 
weeks 
25 54.2 ----- ------- 
Shimzu  
et al., 201359 
YE SBP  
(mm Hg) 
21 134.6 15.3 8 
weeks 
21 135.1 10.6 pa = .89 
OE  SBP 
(mm Hg) 
8 132.5 17.7 8 
weeks 
8 128.8 22.0 pa = .69 
YE DBP 
(mm Hg) 
21 78.5 11.2 8 
weeks 
21 76.9 8.4 pa = .49 
OE DBP 
(mm Hg) 
7 70.4 9.3 8 
weeks 
7 70.1 20.0 pa = .96 
Fabre et al., 
200222 
 VO2max 
(ml·min-1) 
8 1256 100 8 
weeks 
8 1265 115 p >.05 
Linde et al., 
201469 
 VO2max 
(ml·min-1 
·kg-1) 
13 23.9 8.3 16 
weeks 
13 29.0 7.5 pa<.01* 
Control YE: Control younger elder; Control OE: Control older elderly; CBF-RIPC: Cerebral Blood Flow in right inferior prefrontal 
cortex. 
Pa: Paired t test, compared before and after in each group; p=/<*: significant 
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Table 7: Intervention Group(s) Results 
Author, 
Year 
Intervention 
Group 
CV 
Outcome 
Baseline Follow-Up P-
Value 
   
N Mean SD Time N Mean SD  
Mozolic  
et al., 
201068 
Attention 
and 
distractibility 
CBF-RIPC 
(ml/100·g 
tissue/min) 
23 43.6 ----- 8 
weeks 
23 59.2 ----- p <.05*  
Shimzu 
et al., 
201359 
YE SBP  
(mm Hg) 
32 140.1 17.7 8 
weeks 
32 129.0 15.3 pa = .00* 
OE SBP 26 128.5 19.8 26 125.2 17.1  pa = 
.434 
YE DBP 32 76.4 8.7 32 73.1 9.2 pa = .05* 
OE DBP 26 66.9 12.6 26 65.9 8.9 pa = .613 
Fabre et 
al., 
200222 
Aerobic 
Training 
VO2max 
(ml· min-1) 
8 1350 510 8 
weeks 
8 1630 146 p<.05* 
Mental 
Training 
VO2max 
(ml· min-1) 
8 1060 116 8 999 118 p>.05 
Aerobic + 
Mental 
Training 
VO2max 
(ml· min-1) 
8 1510 109 8 1625 109 p<.05* 
Linde et 
al., 
201469 
Physical 
Training 
VO2max 
(ml·min-1 
·kg-1) 
15 25.2 8.4 16 
weeks 
15 27.9 6.3 pa = .02* 
Cognitive 
Training 
VO2max 
(ml·min-1 
·kg-1) 
11 25.4 7.7 11 27.9 8.3 pa = .05* 
Physical + 
Cognitive 
Training 
VO2max 
(ml·min-1 
·kg-1) 
16 24.1 10.0 16 28.9 8.7 pa = .01* 
 
Intervention YE: Intervention younger elder; Intervention OE: Intervention older elderly; CBF-RIPC: Cerebral Blood 
Flow in right inferior prefrontal cortex; Pa: Paired t test, compared before and after in each group; p=/<*: significant   
 31 
 
DISCUSSION 
This systematic review examined the effects of cognitive training on vascular health in 
community-dwelling older adults who were either healthy or cognitively impaired. Four 
articles qualified for qualitative analysis, demonstrating the paucity of research in this 
field. The eligible studies were published within the past 13 years (2002-2015), 
signifying the effects of CT particularly on vascular health in older adults is still in its 
nascent stage. However, this review still offers direction for research and health care 
systems about specific modalities that have been tried and found to be successful. 
Mozolic et al.68, used non-computerized CT to significantly increase CBF, whereas 
Shimzu et al.59, used music therapy to significantly decrease both SBP and DBP. 
Although this review cannot definitively state CT interventions are paramount due to 
limitations in study design, the studies included in this review and others who did not 
meet the review criteria but still included  CT73,74 have found significant improvement on 
vascular health.  
Furthermore, CVRFs also implicate cognitive function, especially as we age. An editorial 
in the American Medical Association concluded that the most readily adjustable risk 
factors of dementia were vascular risk factors53.  Fukuhara and colleagues explained a 
possible correlation between atherosclerosis and cognitive impairment whereby 
preventing the occurrence of atherosclerosis would in turn prevent cognitive 
impairment45.  Several longitudinal studies including a one-year study with a non-
demented elderly population with subjective memory complaints was founded to have a 
decline in their MMSE score due to heightened aortic stiffness75. Such findings were 
 32 
 
replicated in the PARTAGE study76, the Baltimore Longitudinal Study of Aging14 and 
The Health ABC sub-study38.  Similar outcomes were found among late-life blood 
pressure and cognition where two studies supported the idea of a “U” shaped association 
concerning blood pressure and a decline in cognitive function37,77 . Nine studies also 
confirmed the detrimental effect of high blood pressure (SBP>150 mm Hg) on cognitive 
function33-35,78-83. Therefore, it is imperative to find a definitive prevention strategy or 
moderator for CV health which will in turn preserve cognitive function, particularly in 
the older adult population. 
Study Limitations 
Mozolic et al., demonstrated a significant impact of CT on CBF in older adults, despite 
being a small pilot study. The addition of a younger population as a control group could 
verify whether training-induced changes are specific to older adults or could be used for 
younger adults as well68. The Naruko Clapper and music therapy study lowered clinical 
blood pressure which could be due to the division of their sample into younger and older 
elderly groups. Furthermore, they encountered a comparatively high dropout rate due to 
the length of the intervention and traveling distance to test locations and should be 
addressed in future studies59. Fabre and colleagues found significant improvements in 
VO2max in two of the three intervention (combined AE and CT; and AE training only) 
groups. They raised a very important variable, anxiety in older adults, to be a possible 
determinant for the lack of improvement in the mental training group alone22. Elderly 
subjects in general are more anxious compared to younger individuals, which can be due 
to a loss of attention span84. Increased energy in the elderly is required in order to match 
 33 
 
the performance of a younger adult; as a result, evidence has shown AE to alleviate 
anxiety82. Therefore, groups involving AE diminish anxiety which could lead to better 
performance compared to mental training alone and should be considered a variable to 
control, if possible, in future studies22. Lastly, Linde et al., found a significant 
enhancement in control and all intervention groups for VO2max. However, their 
methodology could be attributable to their impact in VO2max. For economic reasons, a 
field test was used to estimate VO2max, while still within a valid and acceptable range, 
field tests can lead to bias by test practice or effects of motivation23.  Consequently, the 
increase in cardiovascular fitness among all groups can be partially accredited to either 
one or both effects. Future studies should utilize undeviating methods to examine 
cardiovascular fitness69.  
Limitations of this review should also be noted. A second review for level 1 screening 
was not completed due to time constraints. Moreover, initial study screening with title 
and abstract may lead to limitations with identifying potential intervention studies despite 
including articles for full-text review when uncertain about the title or abstract. In 
addition, one article remained included even though clarification was needed about their 
study population52. Complete data extraction for level 2 screening was not done by the 
second reviewer because a meta-analysis was not possible based on the results of this 
review. Lastly, limitations were set to citations published in English and articles from 
year 2000 onwards, in order to confine the degree of the search yield to a manageable 
amount of articles; therefore, some could have been missed.  
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CONCLUSION 
Overall, the present review examined the possible effects of CT on vascular health in 
community-dwelling older adults who were either healthy or suffered cognitive 
impairment but no dementia. Two of the four articles eligible for qualitative synthesis 
demonstrated the affirmative effects of CT on vascular health (i.e. SBP and DBP); 
however, the other two articles revealed a paradoxical impact on vascular health. It still 
remains unclear whether CT is as favourable other methods for improving vascular health 
(i.e. aerobic exercise or physical activity), which in turn may improve cognition. Future 
studies should elicit the most pragmatic method of CT and add to the evidence base 
regarding whether CT can improve vascular health in older adults. 
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Thesis Objective 
The purpose of this thesis is to elucidate whether a 6-month multiple modality mind-
motor (M4) exercise program elicits similar effects on clinical resting systolic blood 
pressure (SBP) and diastolic blood pressure (DBP), and 24-hour ambulatory systolic 
blood pressure (24-Hr SBP) and diastolic blood pressure (24-Hr DBP) in community-
dwelling older adults (aged 55 years and older) with subjective memory complaints, 
compared to a 6-month multiple modality (M2) exercise program administered alone.  
Secondary objectives 
1) Investigate whether M4 improves 24-hour, daytime, and nighttime peak systolic 
blood pressure (sbppk); peak diastolic blood pressure (dbppk); heart rate (HR); 
common carotid arterial stiffness [(intima-media thickness (IMT) and arterial 
compliance (AC)]; blood flow velocity [systolic pulse wave velocity (Psv), 
diastolic pulse wave velocity (Pdv), end-diastolic pulse wave velocity (Pedv) and 
average pulse wave velocity (Pavg)]; and cardiovascular (CV) fitness (maximum 
volume of oxygen uptake;VO2max), to a similar extent as M2. 
2) Determine if age (younger elderly, YE; versus older elderly, OE) has an impact 
on the improvement of vascular health (24-hour ambulatory and clinical resting 
blood pressure (BP), arterial stiffness, blood flow velocity and cardiovascular 
fitness) between M2 and M4. 
3) Establish whether a difference exists between sex and vascular health (24-hour 
ambulatory and clinical resting BP, arterial stiffness, blood flow velocity and 
cardiovascular fitness) improvement among M2 and M4.  
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Hypotheses 
The M4 and M2 group will have similar improvements in 24-hour ambulatory and 
clinical resting SBP and DBP.  
Secondary Hypotheses 
1) 24-hour, daytime and nighttime sbppk, dbppk, HR, carotid IMT and AC, Psv, Pdv, 
Pedv, Pavg and VO2max will all improve to a similar extent in both M2 and M4 
groups 
2) The YE adults will have greater improvements in vascular health (blood pressure, 
carotid IMT, carotid AC, VO2max and blood flow velocity) compared to older 
adults in both M2 and M4 
3) Females will have greater improvements in vascular health (blood pressure, carotid 
IMT, carotid AC, VO2max and blood flow velocity);  compared to males in both 
M2 and M4 groups   
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Chapter 3: Methods 
 
Subjects 
 
Participants were recruited through various newspaper ads and flyers in local 
establishments, including doctor’s offices in Woodstock, ON. Individuals considered for 
this study were 55 years of age or older who had a subjective cognitive complaint 
including  memory or thinking skills and preserved instrumental activities of daily living 
[based on the Lawton-Brody Instrumental Activities of Daily Living (IADL) scale85]. 
Participants were excluded if they (1) were self-reported or suspected to have dementia 
(i.e. MMSE score <24); (2) had other significant neurological or psychiatric conditions 
(i.e.  Parkinson’s disease, Bipolar disorder, Schizophrenia etc.); (3) severe sensory 
impairment (i.e. blind); (4) previous history of severe CV conditions in the past 2 years 
(i.e. myocardial infarction, end stage congestive heart failure, end stage renal disease, 
stroke etc.); (5) significant orthopedic conditions (i.e. severe arthritis); (6) blood pressure 
<180/100 mmHg or <100/60 mmHg; (7) major depression [based on CES-DS (score 
≥16)] and clinical judgement of primary physician; (8) unable to comprehend 
questionnaire material; and (9) any other reason that would impact ability to fully take 
part in intervention (i.e. cannot commit to approximately 80% of exercise sessions).   
 
All participants gave written informed consent. The study was approved by Western 
University Research Ethics Board for Health Sciences Research Involving Human 
Subjects (Appendix D), Lawson Health Research Institute Research Ethics Board 
approval by CRIC to utilize hospital resources from Parkwood Hospital (Appendix E), 
Clinical trial protocol was registered at clinicaltrials.gov (Appendix F).  
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Study Design 
Screening Assessment 
Participants underwent a screening assessment. Concurrent medical conditions given 
verbally, medical history, medications and three seated blood pressure (BP) 
measurements were collected (Omron Healthcare, Automatic Blood Pressure Monitor, 
Model 1A2, Japan). Questions were asked regarding their memory and thinking skills 
prior to assessing their cognitive function using standardized questionnaires including the 
Mini Mental State Examination (MMSE)86, the Montreal Cognitive Assessment 
(MoCA)87, and an assessment of their ability to engross in daily activities using the 
IADL85. The determination of whether individuals suffered from depression was 
examined through the Center for Epidemiologic Studies: Depression Scale (CES-DS)88. 
If found to have severe untreated depression (score over 16/60), their family physician 
was contacted for further information and consultation with the primary investigator, Dr. 
Petrella to determine best course of action.   
 
Eligible Participants 
Eligible participants completed a 3-day baseline assessment prior to commencing the 6-
month exercise classes. Similarly, the 3-day assessment was conducted at the end of the 
6-month intervention period. The first two days of assessments took place at Salvation 
Army Church (Woodstock, ON) and the third day took place at the Aging, Rehabilitation 
& Geriatric Care (ARGC) Research Centre located in the Parkwood Institute (London, 
ON). On the first day, participants were asked a few questions regarding their general 
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health and current level of physical activity using the Phone-FITT questionnaire89. 
Subjects were then introduced to Cambridge Brain Sciences (CBS), a computer-based 
cognitive battery (www.cambridgebrainsciences.com). The information retrieved from 
the 12 computer games targeted specific domains of cognitive function including 
memory, concentration, reasoning and planning (see Appendix B, Table 1 for description 
and scoring rubric).  On the second assessment day, participants played the 12 computer 
games in their entirety and their results were recorded. On the third day, participants 
underwent a series of measurements including: i) vascular measures: 24-hour ambulatory 
BP (SpacelabsTM ABPM, Model 90207, Spacelabs Inc., Redmond WA, USA), clinical 
resting BP with an automated oscillometric monitor (BP was measured (BpTRUTM, VSM 
MedTech Ltd., Coquitlam, BC), and a carotid artery ultrasound (2-D Ultrasound; GE 
Vingemed System 5); ii) gait and mobility using the reliable and validated GAITRite 
system (platinum version)90, which uses a sensory walkway mat connected to a software 
to record spatio-temporal gait characteristics; and iii) sensorimotor eye-tracking 
assessment (EyeTrac6: Applied Sciences Laboratories, Bedford MA) measuring anti- and 
pro-saccade reaction time and errors.  
Cardiovascular Assessments 
Only the measurements used in this thesis will be described in detail below.  
 
24-Hour ambulatory blood pressure 
At the end of day 1 or day 2 assessments, participants were fitted with a 24-hour 
ambulatory BP monitor. The monitor was worn once at baseline and at the end of the 6-
month intervention. Ambulatory BP measures consisted of average 24-hour, daytime and 
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nighttime SBP, DBP, sbppk, dbppk, mean arterial pressure (MAP) and heart rate (HR) 
recordings. The monitor took a total of 40 readings over the 24-hour period. One 
measurement was taken every half hour during the day between 06:00-22:00, and one 
measurement was taken every hour from 22:00-06:00. The monitor gave a five second 
warning beep as an indicator to the participant to relax their arm prior to inflation of the 
cuff. The monitor beeped once to indicate completion of a successful measurement or 
beeped repeatedly to indicate an error.  In case of measurement error, the cuff 
automatically inflated two minutes later in an attempt to obtain a successful measure.  
Participants were asked to not shower during the 24-hour period in order for the cuff to 
remain on their arm for the entire 24-hour period.  
A BP diary was also given in order for each participant to record any events that could 
cause their BP to increase (i.e. stressful event, laughing hysterically, exercising, etc.). 
First participant asked to wear for another 24 hours where possible.  Average SBP, DBP, 
peak SBP and DBP, MAP, and HR for daytime, nighttime and an overall 24-hour 
summary were recorded along with hourly readings. The cut-off for an adequate amount 
of readings was 50% (20 successful readings) for statistical analysis, otherwise the 
participant was asked to wear the monitor for another 24 hours.  
Ambulatory BP measures give an accurate sense of how the participant’s BP fluctuates 
throughout the day. More readings are taken throughout the day than at night because that 
is the time when the participant is more active/mobile. Therefore, taking more frequent 
measures of BP during the day will give a more accurate depiction of the participant’s 
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BP. Nighttime BP was taken less frequently due to the fact that older adults are more 
sedentary at night.  
Clinical Resting BP 
Clinical resting BP is comparable to measures of what a participant would take if done 
themselves or at a doctor’s office. On the third assessment day, participants reported to 
the laboratory (Aging, Rehabilitation and Geriatric Care Research Centre, Parkwood 
Hospital, London, Ontario, Canada) after abstaining from vigorous exercise (for 24 
hours), alcohol (for 24 hours), caffeine (for 12 hours), smoking (for 12 hours) and fasted 
for a minimum of four hours prior to their appointment to standardize each participant 
prior to their ultrasound91.  A BP cuff was secured around the left upper arm (unless 
contraindicated by other medical issues) approximately two centimeters proximal to the 
antecubital fossa. After five minutes of seated rest, with back and arms supported and feet 
flat on the floor, three brachial artery SBP, DBP and HR were measured in triplicate with 
two minute intervals between cuff inflation91.. The averages of the last two measurements 
were used in analysis. Participants were instructed to relax and remain still and quiet 
throughout the duration of BP measurements.  
Carotid artery intima-media measurement 
Following BP measurements, a common carotid artery ultrasound was performed. The 
carotid artery is an ideal area as it is superficial, easy to access and covers the aorta that 
demonstrates the greatest age-related stiffening92. In almost all cases with few exceptions, 
the same investigator was used to perform all carotid artery ultrasounds at baseline and 6-
months. A second investigator performed the ultrasound at random in order to examine 
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inter-rater reliability. A checklist was completed with each participant preceding the 
ultrasound, ensuring the participant followed instructions regarding no exercise, alcohol, 
caffeine, smoking or food. If deviated, a note was made on the checklist of what they ate 
or did and what time it occurred in reference to their ultrasound appointment. The 
participant was left to lay supine on the bed for ten minutes to regulate their blood flow 
velocity prior to connecting them to an electrocardiogram (ECG) to monitor their beat-to-
beat HR. Two electrodes were placed two finger-widths below the clavicle, one 12 cm 
left of the sternum and the other, 12 cm to the right of the sternum. A third electrode was 
placed two finger-widths above the participant’s right ilium.  
The right common carotid artery was imaged in all participants with their heads turned 
approximately 45º towards the left.   A 10 Mhz transducer was placed longitudinally 
along the right common carotid artery to obtain two-dimensional B-mode ultrasound 
images (Vingmed System 5, GE Ultrasound A/S, Horton, Norway). Image 
standardization of the carotid artery was done whereby all measurements were taken 2-4 
cm away from the carotid artery bulb.  Minimum diameters (diastolic), measuring from 
wall to wall (vessel diameter) commonly coincided with the QRS peak on the ECG. 
Maximum diameters (systolic) were measured from the top of the wall to the outer 
edge/bottom of the endothelial layer, which commonly coincided with the T peak on the 
ECG, however sometimes this had to be done through visual inspection as minimum and 
maximum diameters did not occur according to the ECG. Averages of 3 values for 
systolic and diastolic were used for carotid AC calculations, by which carotid AC was  
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determined by using the following equation: 
            Carotid AC = ∆D/∆P                          (Equation 1) 
 Carotid AC = [π(
𝐷𝑚𝑎𝑥
2
)2 −  π(
𝐷𝑚𝑖𝑛
2
)2]/∆P         
where ∆D is the change in arterial diameter from systole (Dmax) to diastole (Dmin), and ∆P 
is the tonometrically-obtained arterial pulse pressure93-95. 
Carotid IMT was measured on a frozen-frame image, which was magnified to achieve a 
higher resolution of detail and accuracy. Carotid IMT was measured by the subtraction of 
the lumen diameter from the arterial diameter, which resulted in the thickness of 
endothelium in millimeters. Carotid IMT was obtained from three contiguous sites within 
a 2 cm range, the mean of these values were used in statistical analysis96. Normative 
values for carotid IMT for ages 50-59 years is 0.85, while adults 60 years or more 
generally have an IMT of 1.0597.   
Carotid artery blood flow velocity measurement 
Blood flow velocity looks at the rate at which blood flows through the artery to and from 
the heart and the brain. Selecting “pulse wave” on the ultrasound machine, allowed a 
different view on the monitor that required the adjustment of “velocity range” and the 
angle at which blood is flowing. The shorter the velocity range, the larger the signal. 
Doppler ultrasound was used to collect the pulse wave for 60-72 seconds. Three 
consecutive pulse waves were chosen based on similar image properties among them. 
Output recorded for statistical analysis included peak systolic velocity (Psv), peak 
diastolic velocity (Pdv), end-diastolic velocity (Pedv) and average velocity (Pavg). 
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Normative values for blood flow velocity in the common carotid artery for adults aged 
60-85 years98. 
Once the ultrasound component was completed, participants continued to lie on the bed 
as a supine brachial artery BP measurement was done once by placing the same BP cuff 
and monitor used for clinical resting BP measures. Participants were offered a 
standardized snack (granola bar and juice box) upon completion of the ultrasound. 
CV Fitness (VO2max) 
The last CV assessment was a step test, which was completed at baseline, half-way 
through the intervention at 3-months and at 6-months. The step test required the 
participant to climb up-and-down two sets of stairs 20 times while timed with a stop-
watch.  This assessment was used to determine the predicted VO2max for the participant 
and also provide a target heart rate for when they attended the exercise class. The 
equation used to calculate VO2max through Microsoft Excel was the following: 
          𝑉𝑂2 max (
𝑚𝑙
𝑘𝑔
𝑚𝑖𝑛
) = 𝑉𝑂2 (220 − 𝑎𝑔𝑒 − 73 −
(𝑠𝑒𝑥 ×10)
𝐻𝑅−73−(𝑠𝑒𝑥 ×10)
  
          𝑉𝑂2 max (
𝑚𝑙
𝑘𝑔
𝑚𝑖𝑛
) =
1.8×𝑤𝑜𝑟𝑘 ℎ𝑒𝑎𝑟𝑡 𝑟𝑎𝑡𝑒
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡 ×𝑠𝑒𝑥
   
where HR is the heart rate at final stage, 0 represented for men and 1 represented for 
women99.  
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Randomization 
At the end of day 3, the randomization sequence was generated by one of the study 
investigators; and the coordinator was concealed to allocation (used numbered, opaque 
envelopes) using a randomization function (RANDBETWEEN) in Microsoft Excel. 
Assessors were blinded to group allocation.  
Exercise Intervention 
Both exercise groups were led by seniors fitness instructors who were certified through 
the Canadian Centre for Activity and Aging (CCAA). Each exercise session was 60-
minutes in length, conducted 3 times a week for 6 months (see Table 1 for Intervention 
details).  
 
Multiple Modality (M2) Exercise only group 
The multiple modality (M2) exercise is a standard combined fitness class for older adults 
and was developed and guided by the CCAA classes (www.uwo.ca/actage). The M2 only 
group was structured to receive: 1) 5 minute warm-up targeting major joints and slowly 
increasing heart rate, 2) 20 minutes of moderate to vigorous intensity aerobic exercise as 
defined by ACSM guidelines for older adults100, 3) 5-minute cool-down to safely 
decrease heart rate, 4) 10 minutes of resistance training of all major muscle groups 
including core strengthening exercises, 5) 15 minutes of balance training and, 6) 5 
minutes of stretching.   
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Multiple Modality Mind-Motor (M4) intervention group 
The M4 group was similar to the M2 group except modified to incorporate 15 minutes of 
mind-motor exercise. The mind-motor exercise component is best described as a 
visuospatial working memory task, with a stepping response. It is a low-cost, indoor 
exercise program (i.e., Square Stepping Exercise (SSE)) originally designed to improve 
balance and lower extremity functioning in older adults101. The SSE utilizes a floor mat 
grid. In order to successively advance across the mat (motor task), participants were 
required to memorize stepping patterns which get progressively more complex 
(visuospatial working memory task) [see Appendix B. Table 2]. Both groups were 
designed to have the same duration and similar exercises in order to control for 
socialization and activity in general.    
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Table 1: Intervention Details 
 
M2: Multi-Modality Exercise              M4: Multi-Modality, Mind-Motor 
(Exercise Control)                                 (Exercise Intervention) 
Warm-up (5 minutes) 
o Light aerobics 
o Dynamic range of motion of the major 
joints 
Warm-up (5 minutes) 
o Light aerobics 
o Dynamic range of motion of the major 
joints 
 
Aerobic Exercise (20 
Minutes) 
o Large rhythmical endurance activities 
(e.g., walking, marching, sequenced 
aerobics) 
o Keep HR continuously in target zone 
     (i.e. not interval training) 
o Moderate to vigorous intensity 
    Rating perceived exertion (RPE): 5-8 
     on scale of 0-10 
 Participants to check HR ½ way through 
and at end of aerobic exercise. 
Participants will record final RPE and HR. 
 
Aerobic Exercise (20 Minutes) 
o Large rhythmical endurance activities (e.g., 
walking, marching, sequenced aerobics) 
o Keep HR continuously in target zone 
    (i.e. not interval training) 
o Moderate to vigorous intensity 
    Rating perceived exertion (RPE): 5-8 
     on scale of 0-10 
     Participants to check HR ½ way 
     through and at end of aerobic 
     exercise. Participants will record 
     final RPE and HR. 
Aerobic Cool Down (5 minutes) 
o Safely bringing heart rates down 
Aerobic Cool Down (5 minutes) 
o Safely bringing heart rates down 
Resistance Training (10 minutes) 
o Therabands, wall or chair exercises,    
    core strengthening 
o Day 1 – Upper body focus  
o Day 2– Lower body focus  
o Day 3 – Core focus 
Resistance Training (10 minutes) 
o Therabands, wall or chair exercises, core 
strengthening 
o Day 1 – Upper body focus  
o Day 2 – Lower body focus  
o Day 3– Core focus 
Balance & Sham Training (15 
minutes) 
o Keep HR BELOW target zone 
o Dynamic, static and functional     
     balance 
o Breathing and relaxation exercises 
o Finger exercises 
o Range of motion (e.g., arm circles) 
Mind-Motor Training (15 minutes) 
o Keep HR BELOW target zone 
o Square Stepping Exercise (SSE) 
 
Stretching (5 minutes) 
 
Stretching (5 minutes) 
TOTAL:  60 
minutes 
60 min Multi-Modal Exercise 
Training 
TOTAL:  60 
minutes 
45 min Multi-Modal Exercise Training 
15 min Mind-Motor Training 
Table created by: Gill, DP and Stuckey M, M4 Grant study protocol submission.  
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Statistical Analysis 
This study is built off of a larger study whereby a proposed 130 participants (65 
participants per group) was an agreeable sample size. The sample size calculation was 
based on the primary outcome, cognition, with 80% power at the 5% significant level to 
detect an effect size of 0.55102,103. A subsample of the data was collected for the purpose 
of this study, to examine secondary outcomes; therefore analyses were exploratory. A 
sample size calculation using GPower 3.1 free software, was performed after the study 
was completed, with 80% power at the 5% significant level to detect an effect size of 
0.65. The primary outcomes of interest for the current study were difference between 
groups in the following variables: 24-hour SBP, 24-hour DBP, clinical resting SBP and 
DBP, after the M2 and M4 exercise intervention.  
An independent t-test was utilized to assess any baseline differences between group (M2 
and M4), age (YE and OE), and sex (male and female).  Continuous variables were 
checked per approximately normal distribution prior to statistical tests. All mean change 
score outcomes were visually inspected for normality through histograms and the Shapiro 
Wilks statistic. Data are conveyed as mean±standard deviation (SD), unless otherwise 
stated. An ANCOVA was used for all mean change outcomes. Outputs recorded from the 
analyses were estimate mean change, 95% confidence intervals (95% CI) and p-values. 
Each outcome was a separate analysis. Group was the fixed factor and baseline was 
adjusted for the outcome of interest. Two sensitivity analyses were conducted for each 
outcome: 1) analyses were stratified for age and sex and created a separate stratum, and 
2) analyses were restricted to all-completers (i.e., 41 participants). Interpretation is based 
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primarily on point estimates and 95% confidence intervals (CIs).  All statistical tests had 
significance set at p<.05. SPSS for Windows (Version IBM SPSS Statistics 20) was used 
to perform all statistical analyses.  
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Chapter 4: Results 
The results are divided into three sections. The first section focuses on all CV outcomes 
compared by group (M2 vs. M4). Although the gold standard is to include all participants 
randomized regardless of compliance (intent-to-treat) which balances known and 
unknown confounders, at the end of the section, a table with compliant participants 
(80%+) only are included to view the impact of the actual intervention. The second 
section focuses on all CV outcomes compared by group and age. The last section focuses 
on all CV outcomes compared by group and sex.  
4.1 Descriptive Measures  
Overall, 122 participants inquired about the study however, 33 participants were 
excluded: 1) 23 participants were deemed eligible however; they declined to participate 
in the study because of time commitment or personal issues; 2) 10 participants were 
ineligible due to the study’s specific criteria including: i.2 participants did not have a 
cognitive complaint; ii. 5 participants had a significant neurological or 
neuropsychological condition (i.e. Bipolar Disease, Dementia, Alzheimer’s disease); iii. 1 
participant scored less than 24 on the MMSE; iv. 1 participant had extreme hypertension, 
greater than 180/100; v. 1 participant had severe depression (scored 41/60).  
 
A total of 89 participants were recruited and assessed at baseline (27 males, 61 females) 
which were included for baseline characteristics, however 4 participants with baseline 
data  dropped out during the intervention. See Figure 1 for consort diagram.  
From the 89 participants recruited, 74 participants completed the study however, only 41 
participants adhered to a minimum of 80% attendance (absent for a total of 14 classes or 
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less) for the exercise classes. 33 individuals did not meet the 80% compliance however 
their data was still used in statistical analyses. Deviations from compliance were due to 
scheduled vacations, medical surgeries or personal reasons.  
Demographics and medical history are located in Table 1 by group (M2 compared to 
M4).  
The M2 group contained 41 participants, whereas the M4 group had 48 participants. The 
M2 group’s average age of 66 years was younger by one year compared to the M4 group 
respectively. Majority of the participants were Caucasian with the exception of 2 African 
Americans and 1 participant classified as ‘other’ ethnicity. More than half of the 
participants were married in both groups and had the same years of average education (14 
years) received. BMI was nearly the same between the two groups with M2’s mean BMI 
of 30.26 and M4’s mean BMI 29.14. It is suggested by MedlinePlus, older adults should 
have a BMI slightly higher (between 25-27) as oppose to under 25, due to potential 
protective factors such as osteoporosis (nlm.nih.gov/medlineplus/osteoporosis.html). 
More than half of participants drank alcoholic beverages on a weekly basis in both 
groups, with each group having one person who smoked concurrently.  Two assessments 
were used to determine whether any cognitive impairment existed. The first assessment 
was the Mini-Mental State Examination (MMSE), and the second assessment was the 
Montreal Cognitive Assessment (MoCA), by which both had a maximum score of 30. 
The average scores were nearly the same for both groups on the MMSE (mean score of 
29), and MoCA (mean score of 25). An MMSE score of <24 indicates an increased odds 
of dementia, a range of 24-30 has very little severity and translates to no cognitive 
impairment86. A MoCA score of 26 or greater is considered normal for older adults135, 
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therefore, our study population scored high on the MMSE but had an average score on 
the MoCA, just below the accepted range, indicating some display of cognitive 
impairment.   
Medical history and medication was documented, specifically any cardiovascular 
medication or medications that influence the cardiovascular health. A total of 49 
participants were diagnosed by a physician as hypertensive, with 31 individuals who 
were medicated. In total, 34 participants were diagnosed with high cholesterol, but only 
22 participants were treated with medication. There were 8 participants with diabetes; 
however, only 7 of them were medicated. A total of 13 participants reported having heart 
trouble with all of them treated for with medication including blood thinners, heart or 
other CV medication.  
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Figure 1: Consort Diagram 
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Table 1. Demographics and Medical History by Group 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: BMI, body mass index; MMSE, Mini-Mental Status Examination; MoCA, Montreal 
Cognitive Assessment; pVO2max, Predicted Maximal Oxygen Uptake; a Data were missing for pVO2max 
score in 2 participants and for body mass index in 1. Percentages are calculated excluding missing values 
(where applicable). b Participants were asked to rate their memory on a scale of 5 (from much better to 
much worse); cOther CV conditions Total was for heart trouble only due insufficient data for any other CV 
conditions recorded, medicated individuals included blood thinners, heart or arterial medication 
Baseline CV outcomes by group are presented in Table 2. All CV variables at baseline 
were approximately normally distributed which were confirmed by normality tests. If 
they were not significant, an appropriate log transformation would have been done to 
normally distribute the data.   
 
Characteristic M2 (n = 41) M4 (n = 48) 
Age, y, mean (SD) 66.90 (6.38) 67.77 (7.46) 
Female Sex, No. (%) 31 (75.61) 31 (64.58) 
Caucasian, No. (%) 40 (97.56) 46 (95.83) 
Married, N (%) 24 (58.54) 27 (56.25) 
Education, y, mean (SD) 13.61 (3.36) 13.17 (2.70) 
BMI, mean (SD) 30.26 (6.57) 29.14 (4.09) 
Drink alcoholic beverages, No. 
(%) 
25 (60.98) 28 (58.33) 
Current Smoker, No. (%) 1 (2.44) 1 (2.10) 
Former Smoker, No. (%) 19 (46.34) 25 (52.08) 
MMSE score (max 30), mean 
(SD) 
29.05 (1.18) 29.00 (1.20) 
MoCA score (max 30), mean 
(SD) 
25.59 (2.56) 25.23 (2.81) 
Medical History 
Hypertension, No. (%) 
Total (n = 49) 20 (40.82) 29 (59.18) 
Medicated, (n = 31) 12 (38.71) 19 (61.29) 
High Cholesterol, No. (%) 
Total (n = 34 ) 16  (47.06) 18 (52.94) 
Medicated (n = 22)  8 (36.37) 14 (63.64) 
Diabetes, No. (%) 
Total (n = 8) 3 (37.50) 5 (62.50) 
Medicated (n = 7) 3 (42.86) 4 (57.14) 
Other CV conditions (i.e. COPD), No. (%) 
Total  (n = 13) 7 (53.85) 6 (46.15) 
Medicated (n = 13) 3 (23.08) 10 (76.92) 
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Table 2: Baseline CV Outcomes by Group 
Abbreviations: Estimate of ∆, estimate of  change; BP, blood pressure; Hr, hour; CV, Cardiovascular  24-
HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial 
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime 
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak 
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max, 
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers 
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50% 
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. 
 
 
 
Baseline CV Outcomes M2 M4 
 N Mean ± SD N Mean ± SD 
Ambulatory BP 
24-Hr Systolic BP 38 130.00 ± 14.35 47 127.26 ± 11.73 
24-Hr Diastolic BP 38 74.37 ± 8.92 47 72.98 ± 8.47 
24-Hr peak systolic BP 38 157.58 ± 17.48 47 153.83 ± 17.51 
24-Hr peak diastolic BP 38 95.84 ± 11.25 47 92.83 ± 10.78 
24-Hr MAP 38 94.32 ± 9.99 47 91.94 ± 10.06 
24-Hr HR 38 71.68  ± 6.87 47 71.57 ± 8.61 
Day Systolic BP 38 132.13 ± 14.34 47 129.47 ± 11.58 
Day Diastolic BP 38 76.11   ± 9.24 47 74.85 ± 8.89 
Day peak systolic BP 38 157.08 ± 18.24 47 153.51 ± 16.00 
Day peak diastolic BP 38 95.74 ± 11.68 47 92.83 ± 10.78 
Day MAP 38 96.26 ± 10.24 47 94.40 ± 9.06 
Day HR 38 72.84 ± 7.36 47 72.87 ± 8.77 
Night systolic BP 38 121.13±  16.48 47 116.62 ± 20.37 
Night diastolic BP 38 66.74 ± 8.99 47 65.53 ± 8.48 
Night peak systolic BP 38 138.74 ± 17.01 47 133.72 ± 17.49 
Night peak diastolic BP 38 80.66 ± 9.40 47 77.28 ± 10.14 
Night MAP 38 86.37 ± 10.54 47 84.96 ± 9.34 
Night HR 38 66.68 ± 6.50 47 66.55 ± 9.19 
Clinical Resting BP 
SBP 41 142.05 ± 19.24 48 136.25 ± 17.05 
DBP 41 83.00 ± 11.01 48 81.29 ± 10.86 
Stiffness and Blood Flow 
Carotid IMT 41 .69 ±.16 48 .65 ±.13 
Carotid AC 39 .83 ±.35 46 .90 ±.32 
Psv 41 59.65 ± 17.07 48 60.72 ± 14.65 
Pdv 41 17.11 ± 4.80 48 16.92 ± 4.97 
Pedv 41 18.47 ± 5.20 48 19.40 ± 8.48 
Pavg 41 29.96 ± 8.25 48 30.48 ± 8.07 
CV Fitness 
VO2max 41 25.56 ± 8.38 48 27.44 ± 8.40 
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4.2 Results by Group 
Results between groups can be found in Table 3 and Figure 2. Only two CV outcome 
variables, there was a significant difference between groups (M2 group was used as the 
reference) from the ANCOVA analysis. Nighttime peak SBP, increased after the 6 month 
intervention period compared to the M2 group. The mean group difference after 6-
months revealed an average decrease change of 6.55 mmHg (95%CI: -12.90,-.10; p=.04) 
between the two groups. Clinical resting SBP also improved significantly more compared 
to the M2 group. Between group difference revealed an average decrease of 6.99 mmHg 
(95%CI: .60, 12.37; p=.03).  
Although not statistically significant (p<.05), two blood flow velocity variables showed 
clinical significance.  Pdv showed trends towards worsening in the M4 group after the 
intervention whereas Pedv showed improvement in the M4 group. Pdv between the two 
groups, had an average decrease of 1.22 mmHg (95%CI: -2.59, .15; p=.09). The between 
group differences for Pedv revealed a decrease by 1.22 mmHg (95%CI: -2.59, .15; 
p=.08). 
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Table 3: CV Outcomes Mean Change between M2 and M4 after 6 Months 
Abbreviations: Estimate of ∆, estimate of  change; BP, blood pressure; Hr, hour; CV, Cardiovascular  24-
HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial 
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime 
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak 
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max, 
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers 
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50% 
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as 
reference. *clinical significance (p-value between .06-.09); **significant (p≤.05) 
 
 
 
CV Outcome Variables Between Group Differences 
 Estimate 
Mean ∆ 
95% C.I 
(lower bound, upper 
bound) 
P-value 
Ambulatory BP 
24-Hr Systolic BP -.46 -4.03 3.10 .80 
24-Hr Diastolic BP .14 -2.16 2.43 .91 
24-Hr peak systolic BP -1.38 -6.30 3.54 .58 
24-Hr peak diastolic BP -1.74 -6.08 2.61 .43 
24-Hr MAP -.77 -2.96 1.43 .49 
24-Hr HR -1.01 -3.81 1.80 .48 
Day Systolic BP -.38 -3.73 2.96 .82 
Day Diastolic BP -1.17 -6.76 4.42 .68 
Day peak systolic BP -.08 -4.69 4.53 .97 
Day peak diastolic BP -.82 -.490 3.26 .69 
Day MAP -.69 -3.37 1.99 .61 
Day HR -1.08 -3.89 1.73 .45 
Night systolic BP -1.92 -6.53 2.69 .41 
Night diastolic BP .29 -2.69 3.26 .85 
Night peak systolic BP -6.55 -12.90 -.19 .04** 
Night peak diastolic BP -.12 -4.92 4.69 .96 
Night MAP 1.11 -1.99 4.21 .48 
Night HR -1.42 -4.24 1.41 .32 
Clinical Resting BP 
SBP 6.99 .60 13.37 .03** 
DBP 2.82 -.86 6.51 .13 
Stiffness and Blood Flow Velocity 
Carotid IMT -.03 -.08 .02 .17 
Carotid AC .06 -.04 .16 .23 
Psv -3.24 -8.03 1.55 .18 
Pdv -1.26 -2.71 .19 .09* 
Pedv -1.22 -2.59 .15 .08* 
Pavg -1.90 -4.26 .47 .11 
CV Fitness 
VO2max .28 -1.70 2.26 .78 
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 a)           b) 
 
 c)           d)       
 
 
 
Figure 2: Significant and Clinical Changes after 6 Months between Groups. 
Effects of 6 months of M2 and M4 training on: (a) Night sbppk, nighttime peak systolic blood pressure (b) 
Clinical resting SBP, clinical resting systolic blood pressure; (c) Pdv, peak diastolic velocity; (d) Pedv, end-
diastolic velocity. Point estimates and 95%CI (confidence intervals; lower and upper bound) bars presented; 
*clinical significance (p-value between .06-.09); **significant (p≤.05) 
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In the analysis with compliant participants (80 %+) included only, results indicate only 
nighttime peak SBP had a significant decrease between group, which was similar to the 
findings of the combined compliance and non-compliant participant analyses. The M4 
group increased compared to the M2 group which decreased in nighttime peak SBP. 
Conversely, in the compliant participants’ only analysis, the M2 group had a significant 
positive reduction in carotid IMT compared to the M4 group which increased, see Table 
4 for compliant only participants.                                                                                                                                                                     
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Table 4: CV Outcomes Mean Change Between M2 and M4 with Compliant (80 %+) 
Participants Only after 6 Months 
Abbreviations: Estimate of ∆, estimate of  change; BP, blood pressure; Hr, hour; CV, Cardiovascular  24-
HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial 
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime 
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak 
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max, 
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers 
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50% 
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as 
reference. **significant (p≤.05) 
 
 
CV Outcomes  Between Group Differences 
 Estimate 
Mean ∆ 
95% Confidence Interval 
(lower bound, upper 
bound) 
P-value 
Ambulatory BP 
24-Hr Systolic BP -1.83 -6.46 2.91 .43 
24-Hr Diastolic BP .03 -3.44 3.50 .99 
24-Hr peak systolic BP -2.87 -11.03 5.29 .48 
24-Hr peak diastolic BP -5.58 -12.63 1.48 .12 
24-Hr MAP -.93 -3.34 1.49 .44 
24-Hr HR .31 -3.41 4.02 .87 
Day Systolic BP -2.06 -6.84 2.71 .39 
Day Diastolic BP -1.73 -9.59 6.13 .66 
Day peak systolic BP -2.66 -10.26 4.94 .48 
Day peak diastolic BP -2.54 -9.37 4.29 .45 
Day MAP -.98 -4.46 2.50 .57 
Day HR .15 -3,58 3.87 .94 
Night systolic BP -3.03 -10.05 3.99 .39 
Night diastolic BP -1.20 -6.09 3.69 .62 
Night peak systolic BP -11.54 -22.46 -.62 .04** 
Night peak diastolic BP -1.73 -10.00 6.54 .67 
Night MAP .23 -5.88 6.34 .94 
Night HR .51 -3.46 4.49 .79 
Clinical Resting BP 
SBP -.98 -8.69 6.73 .80 
DBP .03 -4.61 4.68 .99 
Stiffness and Blood Flow Velocity 
Carotid IMT -.08 -.15 -.01 .03** 
Carotid AC -.01 -.14 .13 .95 
Psv -3.61 -9.96 2.74 .26 
Pdv -.97 -2.76 .82 .28 
Pedv -1.31 -3.06 .43 .14 
Pavg -1.25 -4.28 1.79 .41 
CV Fitness 
VO2max .50 -2.34 3.34 .72 
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4.3 Results within Age by Group 
For further analysis, groups were separated and analyzed by “younger” elderly (YE) and 
“older” elderly (OE) as determined by the data given on age. When stratified by age and 
group, analyses within YE and within OE between groups revealed different significant 
CV outcomes. When the YE were analyzed by between group effects, Pedv decreased by 
an average of 2.17 (95%CI: -4.42, .08; p=.05), however the improvement was seen in the 
M2 group not in the M4 group, see Table 5 and Figure 3.  
The OE group only had a significant change in three ambulatory BP variables: 24-hour 
HR, daytime HR and nighttime peak SBP. 24-hour HR decreased in both groups however 
the M2 group further decreased compared to its counterpart. Between group difference 
for 24-hour HR in the OE revealed a mean difference of -4.86 (95%CI: -9.26, -.47; 
p=.03). Daytime HR increased in the M4 group compared to the M2 group which 
decreased. The mean difference in daytime HR for the OE, between groups was -4.84 
(95%CI: -9.24, -.44; p=.03). Lastly, nighttime peak SBP decreased in the M2 group but 
increased in the M4 group. The between group mean difference in nighttime peak SBP 
for OE was -11.24 (95%CI: -21.13, -1.34; p=.03), see Table 6 and Figure 4.  
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Table 5: Mean Difference between M2 and M4 for YE Participants after 6 Months 
CV Outcome Variable Younger Elderly 
 Mean 
Difference 
95% Confidence Interval 
(lower bound, upper 
bound) 
P-Value 
Ambulatory BP 
24-Hr Systolic BP .31 -3.85 4.47 .88 
24-Hr Diastolic BP 1.66 -4.77 1.45 .29 
24-Hr peak systolic BP 3.19 -3.30 9.69 .32 
24-Hr peak diastolic BP -.32 -6.56 5.92 .92 
24-Hr MAP -.02 -2.85 2.81 .99 
24-Hr HR 2.04 -1.52 5.60 .25 
Day Systolic BP -.07 -4.58 4.44 .98 
Day Diastolic BP -.10 -8.26 8.06 .98 
Day peak systolic BP 2.95 -3.35 9.25 .35 
Day peak diastolic BP .04 -6.33 6.42 .99 
Day MAP 1.52 -1.46 4.51 .31 
Day HR 2.03 -1.57 5.62 .26 
Night systolic BP .21 -5.15 5.58 .94 
Night diastolic BP .69 -3.51 4.89 .74 
Night peak systolic BP -.83 -9.63 7.97 .85 
Night peak diastolic BP .72 -7.61 9.06 .86 
Night MAP .93 -3.30 5.16 .66 
Night HR -.87 -4.27 2.53 .60 
Clinical Resting BP 
SBP 8.00 -1.28 17.28 .09* 
DBP 3.79 -1.12 8.69 .13 
Arterial Stiffness and Blood Flow Velocity 
Carotid IMT -.04 -.09 .02 .18 
Carotid AC .13 -.02 .28 .09* 
Psv -4.49 -10.93 1.95 .17 
Pdv -2.17 -4.42 .08 .058 
Pedv -2.29 -4.56 -.01 .05** 
Pavg -3.19 -6.63 .24 .06* 
CV Fitness 
VO2max -.27 -3.02 2.49 .85 
Abbreviations: Estimate of ∆, estimate of  change; BP, blood pressure; Hr, hour; CV, Cardiovascular  24-
HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial 
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime 
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak 
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max, 
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers 
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50% 
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as 
reference. *clinical significance (p-value between .06-.09); **significant (p≤.05) 
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Table 6: Mean Difference between M2 and M4 for OE Participants after 6 Months 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: Estimate of ∆, estimate of  change; BP, blood pressure; Hr, hour; CV, Cardiovascular  24-
HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial 
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime 
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak 
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max, 
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers 
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50% 
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as 
reference. **significant (p≤.05) 
 
 
 
CV Outcome Variable Older Elderly 
 Mean 
Difference 
95% Confidence Interval 
(lower bound,  upper 
bound) 
P-Value 
Ambulatory BP 
24-Hr Systolic BP -.41 -6.71 5.89 .90 
24-Hr Diastolic BP -.54 -3.93 2.84 .75 
24-Hr peak systolic BP -5.60 -13.29 2.08 .15 
24-Hr peak diastolic BP -3.12 -10.01 3.78 .36 
24-Hr MAP -.47 -4.15 3.20 .79 
24-Hr HR -4.86 -9.26 -.47 .03** 
Day Systolic BP .72 -4.55 5.99 .78 
Day Diastolic BP -3.20 -11.52 5.12 .44 
Day peak systolic BP -2.79 -10.06 4.49 .44 
Day peak diastolic BP -1.44 -7.59 4.70 .63 
Day MAP -1.76 -6.58 3.06 .46 
Day HR -4.84 -9.24 -.44 .03** 
Night systolic BP -3.30 -11.53 4.93 .42 
Night diastolic BP .70 -3.67 5.08 .74 
Night peak systolic BP -11.24 -21.13 -1.34 .03** 
Night peak diastolic BP -.88 -7.26 5.50 .78 
Night MAP 2.87 -2.68 8.42 .30 
Night HR -2.37 -7.40 2.66 .34 
Clinical Resting BP 
SBP 6.86 -3.16 16.88 .17 
DBP 2.87 -2.89 8.64 .32 
Arterial Stiffness and Blood Flow Velocity 
Carotid IMT -.04 -.13 .05 .40 
Carotid AC -.04 -.20 .12 .63 
Psv -2.40 -10.15 5.34 .53 
Pdv -.41 -2.41 1.59 .68 
Pedv -.28 -1.87 1.32 .72 
Pavg -.60 -4.22 3.02 .74 
CV Fitness 
VO2max .97 -2.38 4.32 .56 
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a) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – YE Significant Outcomes in End-Diastolic Blood Flow Velocity between 
Groups. Effects of 6 months of M2 and M4 training on: (a) Pedv, end-diastolic velocity. Point estimates and 95%CI 
(confidence interval; lower and upper) bars presented; **significant (p≤.05). 
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a) 
   
 
 
 
 
  
 b) 
  
 
 
 
 
 
 
  
 c) 
 
 
 
 
 
 
 
 
 
Figure 4 – OE Significant Outcomes in Ambulatory BP between Groups. Effects of 6 
months of M2 and M4 training on: (a) 24-Hr HR, 24-hour hear rate; (b) Day HR, daytime heart rate; (c) Night Sbppk, 
nighttime peak systolic blood pressure. Point estimates and 95%CI (confidence intervals; lower and upper) bars 
presented; **significant (p≤.05) 
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4.4 Results by Sex 
 Additional analyses were completed based on sex and group to see whether one sex 
improved over the other. Both males and females differed on which CV variables 
changed significantly.  
Males only significantly changed in nighttime HR. The M4 group increased in night HR 
compared to the M2 group which decreased. Mean difference between groups was -7.36 
(95%CI: -13.05, -1.66; p= .01), see Table 7 and Figure 5.  
Conversely, females significantly changed in nighttime peak SBP clinical resting DBP 
and end-diastolic velocity. Nighttime peak SBP increased in the M4 group compared to 
the M2 group which decreased.  Female nighttime peak SBP had a mean group difference 
of -7.34 (95%CI: -14.36, -.32). Clinical resting DBP had a greater decrease in the M4 
group compared to the M2 group with a between groups mean change of 4.20 (95%CI: 
.09, 8.31; p=.05). End-Diastolic velocity within females increased in the M4 group 
compared to the M2 group which decreased. Mean difference for females between groups 
was -1.65 (95%CI: -3.31, .01; p=.05), see Table 8 and Figure 6.  
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Table 7: Mean Difference between M2 and M4 for Males Only Participants 
between groups after 6 Months 
Abbreviations: Estimate of ∆, estimate of  change; BP, blood pressure; Hr, hour; CV, Cardiovascular  24-
HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial 
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime 
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak 
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max, 
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers 
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50% 
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as 
reference. *clinical significance (p-value between .06-.09); **significant (p≤.05) 
 
 
CV Outcome Variables Males 
 Mean 
Difference 
95% Confidence Interval 
(lower bound, upper bound) 
P-Value 
Ambulatory BP 
24-Hr Systolic BP -2.79 -12.54 6.95 .55 
24-Hr Diastolic BP -2.31 -7.41 2.79 .35 
24-Hr peak systolic BP -1.94 -12.74 8.86 .71 
24-Hr peak diastolic BP -3.93 -13.43 5.58 .40 
24-Hr MAP -2.52 -7.57 2.52 .31 
24-Hr HR -5.08 -10.79 .63 .08* 
Day Systolic BP -1.32 -8.59 5.95 .71 
Day Diastolic BP -6.00 -16.34 4.32 .24 
Day peak systolic BP -2.70 -12.97 7.58 .59 
Day peak diastolic BP -4.70 -13.46 4.06 .27 
Day MAP -2.90 -9.51 3.72 .37 
Day HR -5.06 -10.78 .65 .08* 
Night systolic BP -5.78 -16.85 5.30 .29 
Night diastolic BP -1.66 -9.13 5.81 .65 
Night peak systolic BP -4.56 -19.57 10.46 .53 
Night peak diastolic BP -1.97 -12.21 8.27 .69 
Night MAP -1.17 -7.75 5.40 .71 
Night HR -7.36 -13.05 -1.66 .01** 
Clinical Resting BP     
SBP 11.32 -4.09 26.74 .14 
DBP 1.93 -5.86 9.74 .61 
Arterial Stiffness and Blood Flow Velocity 
Carotid IMT -.03 -.13 .07 .51 
Carotid AC .13 -.10 .36 .25 
Psv -1.31 -11.52 8.90 .79 
Pdv -1.00 -4.04 2.04 .50 
Pedv -.34 -3.10 2.42 .80 
Pavg -1.27 -6.53 3.99 .62 
CV Fitness     
VO2max ..23 -4.01 4.48 .91 
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Table 8:  Mean Difference between M2 and M4 for Females Only Participants 
between groups after 6 Months 
Abbreviations: Estimate of ∆, estimate of  change; BP, blood pressure; Hr, hour; CV, Cardiovascular  24-
HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial 
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime 
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak 
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max, 
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers 
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50% 
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as 
reference. *clinical significance (p-value between .06-.09); **significant (p≤.05) 
 
 
 
CV Outcome Variables Females 
 Mean 
Difference 
95% CI P-Value 
Ambulatory BP 
24-Hr Systolic BP .55 -3.02 4.12 .76 
24-Hr Diastolic BP 1.15 -1.39 3.70 .37 
24-Hr peak systolic BP -1.14 -6.99 4.72 .70 
24-Hr peak diastolic BP -1.35 -6.43 3.73 .59 
24-Hr MAP .04 -2.35 2.43 .98 
24-Hr HR .59 -2.43 3.60 .70 
Day Systolic BP -.05 -4.01 3.92 .98 
Day Diastolic BP 1.17 -5.85 8.19 .74 
Day peak systolic BP .94 -4.48 6.37 .73 
Day peak diastolic BP .51 -4.38 5.39 .84 
Day MAP .60 -2.05 3.24 .65 
Day HR .44 -2.66 3.55 .78 
Night systolic BP -.16 -5.09 4.76 .95 
Night diastolic BP 1.50 -1.52 4.53 .32 
Night peak systolic BP -7.34 -14.36 -.32 .04** 
Night peak diastolic BP .94 -4.90 6.77 .75 
Night MAP 2.47 -1.38 6.32 .20 
Night HR .78 -2.30 3.85 .61 
Clinical Resting BP 
SBP 3.99 -3.17 11.15 .27 
DBP 4.20 .09 8.31 .05** 
Arterial Stiffness 
Carotid IMT -.03 -.10 .04 .40 
Carotid AC .05 -.05 .15 .32 
Psv -3.70 -9.11 1.71 .18 
Pdv -1.42 -3.16 .32 .11 
Pedv -1.65 -3.31 .01 .05** 
Pavg -2.18 -4.92 .56 .12 
CV Fitness 
VO2max .48 -1.81 2.78 .67 
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Figure 5 – Males Significant Outcomes in Ambulatory BP between Groups.  Effects of 
6 months of M2 and M4 training on: (a) Night HR, nighttime heart rate; (b) 24-Hr HR, 24-hour heart rate; (c) Day HR, 
daytime heart rate. Point estimates and 95%CI (confidence interval; lower and upper) bars presented; **significant 
(p≤.05) 
 
 
 
 
 
 
 
 
 
 
 
-12
-10
-8
-6
-4
-2
0
2
4
6
8
0 0.5 1 1.5 2 2.5
M
e
an
 c
h
an
ge
 a
t 
2
4
-w
e
e
ks
Nighttime HR Within Males between 
Groups
M2-Male
M4-Male
**
 70 
 
 a) 
  
 
 
 
 
 b) 
 
 
  
 
 
 
 
 
 
 c) 
 
 
 
 
 
 
 
 
Figure 6 – Females Significant CV Outcomes between Groups. Effects of 6 months of M2 
and M4 training on: (a) Night Sbppk, nighttime peak systolic blood pressure; (b) Clinical resting DBP, clinical resting 
diastolic blood pressure average readings of 2 and 3; (c) Pedv, end-diastolic velocity. Point estimates and 95%CI 
(confidence interval; lower and upper) bars presented; **significant (p≤.05) 
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Correlation Analyses 
 Correlation analyses were conducted at baseline and at 6 months to determine whether 
the intervention was strengthened or diminished between two variables that were 
correlated.  
Bivariate correlation analyses were conducted between 24-hour ambulatory BP variables 
and AC at both baseline and at 6-months. Analyses revealed no strong positive or 
negative relationships at baseline, except for a positive weak relationship between AC 
and 24-hour SBP (r=.22; p=.05), and a negative weak relationship between AC and 24-
hour HR (r=-.25; p=.02). At 6-months the relationship between AC and 24-hour HR 
changed to a strong negative relationship (r= -.05; p≤.01). The remaining variables were 
all negligible or weak relationships. 
Further correlation analyses were performed between AC, age and BMI. Analyses 
revealed at baseline, a weak negative correlation between age and AC at baseline (r=-.02; 
p=.83), after 6-months the relationship was weaker (r=-.12; p=.31).  AC and BMI were 
negligible, however at 6-months, a weak positive relationship was observed (r=.24; 
p=.04). See Appendix C for correlation analyses.  
Adverse Events 
Eight participants suffered an adverse event during the 6-month intervention period. Of 
the eight, half of the participants endured an adverse event during the exercise class. The 
first participant did not suffer any injuries, but found their HR was too high during the 
exercise, and felt a pounding sensation in their chest. The participant walked for 15 mins 
to cool down, and rejoined the class once they felt better. The second participant felt 
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lightheaded after the strength exercise component. The participant sat down and rested 
until they felt better. The third participant felt a sudden pain on the lateral side above 
their knee. Exercises were modified to accommodate the knee pain. The last participant 
fainted, lost their balance and hit their elbow on the wall during stretching at the end of 
the class. Participant got back up and felt fine afterwards. Similarly, another participant 
suffered blurred vision and dizziness; however they felt this way prior to exercise class. 
Another participant suffered from chronic back pain and it worsened; uncertain of 
whether it was exercise class related or not. One participant did not suffer any injuries 
during the exercise class, but had personal medical issues which required placement of 3 
stents. The participant rejoined the class once recovered. The final participant had a 
pinched nerve with leg and back soreness. Pain was amplified during exercise class.  
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Chapter 7: Summary and Conclusion 
Collective evidence has proposed the aging brain as acquiescent to neuronal and 
cognitive plasticity104. Older adults are primarily affected by the decline in cognitive 
domains including memory, language and executive function which are all associated 
with dementia and therefore require critical attention to the prevention and maintenance 
of brain function105,106.  
Contributing factors to vascular health such as diet and physical inactivity play a role in 
the effects of vascular however; blood pressure and arterial health are the single most 
detectable risk factor for dementia excluding age, and the only treatable risk factor to 
date26. Although studies have successfully looked at the use of aerobic exercise to prevent 
and reduce high blood pressure and arterial stiffness in order to promote brain health in 
older adults, the underlying mechanisms are still unclear107.  
The current study is the first prospective, 6-month, randomized controlled trial in a 
community-dwelling older adult population with subjective memory complaints, which 
examines the effects of a multiple modality mind-motor (M4) exercise program on 24-
hour ambulatory and clinical resting BP, compared to a multiple modality (M2) exercise 
program alone. This investigation is notable, as examining the influence of M4 on BP and 
other related CV outcomes within this population is important. Furthering our knowledge 
of potential ways to mediate and support BP reductions and its advancement may 
improve cognitive function and overall risk of CVD within the older adult population.  
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Effects of M2 and M4 on ambulatory BP and clinical resting SBP and DBP 
For the ambulatory BP outcomes, there were no differences between groups except for 
nighttime peak SBP where a significant change was found, with the M2 group decreasing 
in peak nighttime SBP compared to the M4 group. The decrease in peak nighttime SBP 
can aid in the effect of nocturnal dipping, by which nighttime BP should be 10-15% 
lower than daytime BP108. The absence of nocturnal dipping and heightened surge of BP 
during the daytime can lead to specific organ damage and augmented CVD risk, 
including CVD morbidity and mortality109-112.  
On the contrary, the M4 group decreased considerably more compared to the M2 group 
in clinical resting SBP.  This also coincides with the findings of Corneilissen et al., who 
assessed office blood pressure after 10 weeks of either lower or higher intensity training 
in adults (age averaged 59 years). Both types of training reduced office BP, however the 
higher intensity training reduced SBP even further than the lower intensity training 
group112.  
By age and group, within the YE between groups, no significant changes were found in 
any BP measures. Within sex and between groups, both M2 and M4 females decreased in 
clinical resting DBP however the M4 females declined much further. 
Conversely, within the OE between groups, 24-hour HR decreased in the M2-OE group 
compared to the M4-OE group which had an increase in 24-hour HR. Furthermore, these 
findings in 24-hour HR were replicated in daytime HR and nighttime peak SBP. The 
Framingham Heart Study (longitudinal cohort study) followed subjects for 30 years and 
discovered a continuous increase in SBP between the ages of 30 and 84 years or more. 
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However, DBP has a more variable configuration with age, whereby DBP increases until 
the age of 50, and slowly decreases from 60 years onwards, resulting in a steep incline in 
pulse pressure with aging11. Vasan et al., disturbingly re-counted from the Framingham 
Heart Study that 90% of participants, men and women in their mid to late-life were 
probable to develop hypertension onwards throughout the rest of their life113. Therefore, 
growing evidence has shown the importance of controlling for nighttime BP can greatly 
affect the risk of CVD and aging. 
When stratified by sex, within the males in the M2 group, a significant decrease in 
nighttime HR in comparison to the M4 males whose nighttime HR increased. 
Alternatively, females in the M2 group significantly decreased in nighttime peak SBP 
compared to the M4 females who increased in nighttime peak SBP. Sierra et al., found 
after monitoring 24-hour ambulatory blood pressure, those with a non-dipping profile 
were older and often obese women who suffered long-term hypertension, previous 
diagnosis of dyslipidemia, Type 2 Diabetes or CVD114. However, within the current 
study, nocturnal dipping was not accounted for and should be observed in future studies 
as it plays a vital role as we age and between sex.  
In general, M2 and M4 groups both improved in certain variables of ambulatory and 
clinical resting BP, which help decrease the risk of CVD. Furthermore, Beason-Held et 
al., found an association between hypertension and dementia occurrence, whereby studies 
have found hypertension with operating brain measures linked to cerebral blood flow115. 
Positron emission tomography (PET) data collected on participants with hypertension 
(140/90 mm hg) identified with a decline in regional cerebral blood flow over time in 
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several cortical regions, including the prefrontal cortex and anterior cingulate cortex 
compared to participants without hypertension. This suggests brain areas responsible for 
attention and executive function are susceptible to the influences of vascular risk factors 
such as hypertension3.  However limitations do exist as the study did not assess other 
vascular function i.e. cardiac output, endothelial functions or atherosclerotic load which 
could suggest participants with hypertension may not be the sole cause for reducing 
regional cerebral blood flow, but other vascular risk factors that participants may suffer 
from could also contribute to the reduction in regional cerebral blood flow3.  
Furthermore, cross-sectional longitudinal studies have shown a positive correlation 
between hypertension and cognitive decline, whereby subjects who suffered from 
hypertension performed much worse on mental status examinations4. Elevated systolic 
pressures in untreated hypertensive, cognitively normal subjects (mean age, 61.3 years) 
reduced grey matter volumes in different areas of the brain116, and mid-life hypertension 
was associated with a decline in hippocampal volume after a 30 year follow-up7, 
suggesting hypertension can alter the brain structurally leading to abnormalities in 
cognitive function117. Therefore, control for blood pressure subsequently affects not only 
CVD risk, but structural and functional brain alterations. However duration of treatment 
or chronicity of hypertension was not documented, although majority (84%) of 
participants were diagnosed with hypertension for over 10 years, consequently detecting 
the effect of long-term hypertension on the central nervous system117. Better control of 
blood pressure is indicative of the prevention of dementia in late-life.  
Although the current study lacked in number of significant changes in BP, more than half 
of our participants were diagnosed as hypertensive of which only 31 individuals were 
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taking medication. However, their regional cerebral blood flow was not monitored; 
perhaps not many changes in BP occurred because structurally their brain had already 
been altered, to the extent that treating blood pressure could not reverse the effects.  
Therefore, monitoring regional cerebral blood flow in conjunction with BP and its 
possible predictive pathway for dementia could elucidate the appropriate method of 
prevention of hypertension and other vascular risk factors117.  
Additionally, the current investigation was part of a larger-scale study of which 
biological determinants of exercise and cognition are to be explored in further detail.  
Though it is known CV health does play a role in cognition and exercise can improve CV 
health, the influence of CV health on cognition still requires further research.  
 Effects of M2 and M4 on carotid arterial stiffness, blood flow velocity and CV 
fitness 
Neither M2 nor M4 had any significant influence on carotid arterial stiffness (AC and 
IMT), blood flow velocity or CV fitness. It is possible that increasing IMT with age may 
be due to external exposures to risk factors that were not disclosed or known118.  
When further stratified by age, YE improved only in blood flow velocity, of which only 
Pedv had a significant change between M2 and M4. M4-YE had increased in Pedv 
compared to the M2-YE which decreased. Within the OE between groups, no significant 
changes were found in carotid arterial stiffness, blood flow velocity or CV fitness. It was 
determined by Ahzim et al., that an age-associated decline in blood flow velocities in the 
common carotid artery was altered and improved in those who were healthy, middle-aged 
or older who performed habitual aerobic exercise 119. However with reference to this 
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study, improved blood flow velocities of the common carotid artery was only found in 
the M4 group and in the YE group when further stratified, regardless of health or habitual 
exercise.  
The only significance found by sex was a significant change of Pedv in females. The M4 
females had an increase in Pedv whereas the M2 females decreased in Pedv. This 
contradicts the observations by Denarie et al., who did not observe changes in pulse wave 
velocity but rather found a trend in lowering IMT in women than in men on both sides of 
the carotid artery and at different ages; however they found middle-aged adults on the left 
side to have a statistically significant decrease in IMT118. Though, the fact there was no 
significant changes in our study population could attribute to age-related arterial 
hypertrophy in both sexes118. Yet, sex differences in carotid artery dimensions still 
remain unclear.  
CV fitness was not significantly altered when observed by group, within age-between 
groups or within sex-between groups. This was contradictive to studies including Linde 
et al., and Fabre et al., who found improvement in VO2max for almost all of their 
intervention variables except for one (mental training + aerobic training) in the study by 
Fabre et al. Furthermore, they found an increase in their control groups as well22,69.  
Correlation Analyses 
Correlations between AC and blood pressure remained weak or negligible except for AC 
and 24-hour HR which had a strong negative relationship. However, systolic and diastolic 
BP were both highly correlated with their peak BP counterparts for all three time frames 
(24 hours, daytime and nighttime) at baseline. After 6 months, relationships remained 
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strongly correlated to one another. Analyses regarding AC, age and BMI revealed only 
weak correlations both at baseline and at 6-months.  
These correlations are were not very comparable to the findings by Iannuzzi et al., by 
which correlations among age, systolic blood pressure, and BMI were positively 
correlated with external and internal common carotid diameters120.  
7.1 Study Limitations 
The results of the current study are novel and meaningful, however, limitations do exist. 
A limitation of the present study is the data used for ambulatory blood pressure measures. 
Some participants only had the minimum amount of readings (20/40 readings) with very 
few nighttime readings, which could skew the data. Therefore, these results should be 
interpreted with caution. Although a diary was given to the participant to record any 
events that may elevate their blood pressure, some participants may have changed their 
regular routine as a consequence of wearing the monitor for the 24-hours, therefore 
readings could be inaccurate. Another factor that may or may not have been recorded that 
also play a role in the effect of BP, which were not accounted for included anxiety, a 
consequence of the sympathetic nervous system (SNS) influenced by the emotional 
state121. A chronic level of anxiety in a person has been identified to be an association 
between environmental stress and cardiovascular responses that may arbitrate the 
formation of or contribute to chronic hypertension122. 
A limitation was also found in the ultrasound measurement of the common carotid 
arterial wall by which discrepancies in the measurement could have occurred. On 
occasion, arterial wall imaging can be unclear on the ultrasound monitor, or the 
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endothelial layer may not be clearly defined, resulting in subjective measurements, which 
may not be as accurate. Although inter-intra reliability was conducted, it was not reported 
due to greater than average discrepancies in arterial diameters within a participant. The 
discrepancies lie in the movement of the cursor, where a mere single movement of the 
cursor can change the measurement by one- tenths of a millimeter consequently 
increasing the variability in measurements.  
Moreover, ultrasound images were not recorded to allow revisions of the artery and 
ensure accurate measurements were taken. Furthermore, not measuring both left and right 
sides of the carotid artery can also impact results, as they tend to differ over age118. 
Although Denarie et al., also found unknown differences between the right and left, the 
anatomical position of each artery is different. The left common carotid artery is directly 
branched on the aorta whereas the right common carotid results from the division of the 
brachiocephalic trunk. Therefore, it is possible to have differences in arterial growth 
between both arteries118.  
Another limitation was that several participants were under treatment for various 
medications, which could also influence the results. Although BP, cardiovascular and 
other related medications were noted, they were only monitored at the beginning and end 
of the intervention. Some participants in the study had untreated high BP, cholesterol, and 
diabetes, which could also impact the results of the current investigation. Likewise, 
interactions with other medications could have also interfered with the results. In 
addition, reporting bias of medication, medical history and cognitive complaint could 
also be a factor. Some individuals may have said ‘yes’ to having a cognitive complaint 
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but did not actually have any concerns with their memory. Jessen et al., relayed his 
concern of how to conceptualize having a subjective cognitive complaint and determined 
a more accurate way of identifying the at risk population of cognitive decline123. 
Although we asked our participants if they had a subjective cognitive complaint, we did 
not ask them whether or not they were concerned which would determine whether they 
were at risk for cognitive decline in combination with observing AD biomarkers (i.e. 
brain anatomy including glucose metabolism124, amyloid deposition125; cerebral spinal 
fluid markers including Aß42126) that could help identify the preclinical stage of 
cognitive decline, according to Jessen and colleagues.   
Additionally, the current study may be under powered as we only had a total of 89 
participants of which less than half were compliant (80% or more attendance) with the 
exercise class. Therefore, the lack of changes between group, age and group, and sex and 
group could be attributed to the undersized population which affected the statistical 
power of the study.  While stratifying by age and by sex is important, it may not be the 
best way to accurately observe results. Shimzu et al., suggested stratifying by functional 
mobility may be more important than looking between age and sex because an 
individual’s mobility would have an impact on how strenuous an exercise they can 
handle59. Furthermore, some participants may not have reached their target HR each 
class, and therefore did not receive the optimal training to better improve CV health. This 
could also raise the question whether the prescribed exercises were enough to observe a 
change in vascular health.  
Lastly, our study population was predominantly Caucasian, which does not necessarily 
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reflect the population of older adults at large. Therefore, future studies should consider 
more ethnic groups in their population.  
7.2 Perspectives 
As we age, the prevalence of cognitive impairment increases with age and the incidence 
of individuals displaying some form of cognitive impairment prior to meeting any 
diagnostic criteria for dementia (i.e., mild cognitive impairment; MCI, or cognitive 
impairment not dementia; CIND) is doubled, compared to Alzheimer’s disease and 
related dementias127. Therefore, it is imperative to look at older adults who have self-
reported claims of poorer cognition regardless of having an actual indication of cognitive 
impairment to better control the incidence of dementia in later-life128-131.  
Furthermore, CVD risk factors such as hypertension and arterial stiffness are also on the 
rise as we age, and have been confirmed as a contributing factor towards dementia and its 
progression to Alzheimer’s Disease64,132. An editorial in the Journal of the American 
Medical Association states the most readily modifiable risk factors of dementia are 
vascular risk factors. Front-line prevention measures and treatment strategies for CVD 
risk factors include lifestyle modifications such as incorporating habitual, moderate to 
vigorous aerobic exercise133. Aerobic exercise has been proven to mitigate CVD risk 
factors by reducing BP133,134 and arterial stiffness in older adults48.  
Previous research has also found aerobic exercise improved CVD risk factors and 
cognitive function, specifically executive function in healthy older adults and those with 
cognitive impairment20,134-137, demonstrating the association between CVD risk factors 
and cognition . Increases in cardiovascular fitness enhanced important regions of the 
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brain including the attentional network134; however, the neural mechanisms responsible 
for enhancement in cognition due to improved CVD risk factors in aging adults have not 
been fully investigated134. Additionally, cognitive training has also been shown to 
improve executive function and memory in healthy older adults and in cognitively 
impaired older adults21,50.  
Due to the observed fixed association between cognition and vascular health20,134-137, the 
use of cognitive training to improve vascular health the current study incorporated a 
multiple modality and mind-motor training program to see whether both prescriptions 
given together would benefit CVD risk factors, in turn improving cognition in older 
adults.  In addition, elucidating the optimal regimen for preserving CVD risk factors and 
cognition.  
This study conducted a larger-scale randomized controlled trial of community-dwelling 
older adults who have a subjective memory complaint and found some evidence of a 
beneficial impact from a multiple modality mind-motor program on CV health. However 
future research should look at nocturnal dipping and cerebral blood flow as outcome 
measures to understand physiologically, the CV mechanisms within the brain. More 
ethnic groups should also be included to better generalize the findings of the intervention 
in an older adult population. Furthermore, better control of external factors such as 
anxiety and stratifying by physical function levels should be further investigated when 
looking at a combined aerobic and cognitive training exercise program on vascular 
health.   
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Appendix B. Table 1: Description and Scoring Rubric for CBS Games 
 
 
 
 
 
Task Name 
 
Cognitive 
Domain 
 
Brief Description 
 
Outcome Measure 
Literature 
Informing Task 
1. Monkey 
Ladder 
(Visuospatial 
working 
memory) 
Memory Sets of numbered squares are 
displayed all at the same time at 
random locations within an 
invisible 
5x5 grid. 
 
After a variable interval, the 
numbers are removed leaving just 
the blank squares visible. 
 
A tone cues the participant to 
respond by clicking on the 
squares in ascending numerical 
sequence. 
Maximum level achieved 
(Maximum = 25; 
Minimum =2) 
Non-human 
primate 
literature 
142
 
2. Grammatical 
Reasoning 
(Verbal Reasoning) 
Reasoning Problems of the form “The 
square is not encapsulated by 
the circle” are displayed on the 
screen and the participant must 
indicate whether the statement 
correctly describes a pair of 
objects displayed in the centre 
of the screen. 
 
In order to achieve 
maximum points, the 
participant must solve as 
many problems as possible 
within 90 seconds. 
Total score – which 
increases or decreases 
by 1 after each trial 
depending on whether 
responses are correct. 
The first trial has 
four numbers. The 
maximum level is 
25 and the 
minimum level is 2. 
Alan Baddeley’s 
3- minute 
grammatical 
reasoning test 
143
 
3. Double Trouble 
(Color-Word  
Re-mapping) 
Reasoning A colored word is displayed at 
the top of the screen, for 
example the word RED drawn 
in blue ink. 
 
Participants must indicate which 
of two colored words at the bottom 
of the screen describes the color 
that the word at the top of the 
screen is drawn in. 
 
The color word mappings may be 
congruent, incongruent, or 
doubly incongruent, depending 
on whether or not the color that a 
given word describes matches 
 
 
 the color that it is drawn in. 
Total score 
 
To gain 
maximum points, 
the participant 
must solve as 
many problems 
as possible 
within 90 
seconds. 
 
The total score 
increases or decreases 
by 1 after each trial 
depending on whether 
they responded 
correctly. 
More 
challenging 
variant of the 
Stroop test 
144 
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Task Name 
 
Cognitive 
Domain 
 
Brief Description 
 
Outcome Measure 
Literature 
Informing 
Task 
4. Odd One 
Out 
(Deductive 
Reasoning) 
Reasoning A 3x3 grid of cells is displayed on 
the screen. Each cell contains a 
variable number of copies of a 
colored shape. 
The features that make up the 
objects in each cell (color, shape, 
number of copies) are related to 
each other according to a set of 
rules. 
The participant must deduce the 
rules that relate the object features 
and select the one cell whose 
contents do not correspond to those 
rules. 
Total correct 
To gain maximum points, 
the participant must solve 
as many problems as 
possible within 90 
seconds. 
If the response is correct, the 
total score increases by one 
point and the next problem is 
more complex. If the response 
is incorrect, the total score 
decreases by 1 point. 
Sub-set of 
problems 
from the 
Cattell 
Culture Fair 
Intelligence 
Test 
145
 
5. Spatial 
Span 
Blocks 
(Spatial 
Span) 
Memory 16 squares are displayed in a 4x4 
grid. A sub-set of the squares flash in 
a random sequence at a rate of 1 flash 
every 900 ms. 
Subsequently, the mouse cursor is 
displayed and a tone cues the 
participant to repeat the sequence by 
clicking on the squares in the same 
order in which they flashed. 
Maximum level achieved 
(Maximum = 16;  
Minimum = 2) 
Corsi Block 
Trapping 
Task 
146
 
6. Rotations 
(Spatial 
Rotation) 
Concentration In this variant, 2 grids of colored 
squares are displayed to either 
side of the screen with 1 of the 
grids rotated by a multiple of 
90°. 
When rotated, the grids are either 
identical or differ by the position of 
just 1 square. 
In order to gain maximum 
points, the participant must 
indicate whether the grids are 
identical, solving as many 
problems as possible within 90 
seconds. 
 
 
Total score 
If the response is correct, the 
total score increases by the 
number of squares in the grid 
and subsequent trials have 
more squares. 
If the response is incorrect the 
total score decreases by the 
number of squares in the grid 
and subsequent trials have 
fewer squares. The first grids 
contain 4 colored squares each. 
Spatial 
Rotation tasks 
are often used 
for measuring 
the ability to 
manipulate 
objects 
spatially in 
mind 
147
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Task Name 
 
Cognitive 
Domain 
 
Brief Description 
 
Outcome Measure 
Literature 
Informing 
Task 7. Feature 
Match 
 
Concentration Two grids are displayed 
on the screen, each 
containing a set of abstract 
shapes. 
 
In half of the trials the grids 
differ by just one shape. 
 
In order to gain maximum points, 
the participant must indicate 
whether or not the grid’s contents 
are identical, solving as many 
problems as possible within 90 
seconds. 
Total score 
 
If the response is correct, the 
total score increases by the 
number of shapes in the grid 
and the number of shapes in 
subsequent trials increases. 
 
If the response is incorrect, the 
total score decreases by the 
number of shapes in the grid 
and subsequent trials have 
fewer shapes. The first grids 
contain two abstract shapes 
each. 
Classic feature 
search tasks 
that have 
historically 
been used to 
measure 
attentional 
processing 
148
 
8. Digit 
Span 
Memory Participants view a sequence of 
digits that appear on the screen 
one after another. 
 
Subsequently, they repeat the 
sequence of numbers by entering 
them on the keyboard. 
Maximum level achieved 
(Maximum level = 25; 
Minimum level = 2) 
Computerised 
variant on the 
verbal working 
memory 
component 
of the 
WAIS-
R 
intelligence 
test 
149
 
9. 
Hampshire 
Tree Task 
(Spatial 
Planning) 
Planning Numbered beads are positioned 
on a tree shaped frame. 
 
The participant repositions the 
beads so that they are configured 
in ascending numerical order 
running from left to right and top 
to bottom of the tree. 
 
 
 
Total score 
 
After each trial, the total score 
is incremented by adding the 
minimum number of moves 
required ×2 – the number of 
moves actually made, thereby 
rewarding efficient planning. 
Based on 
Tower of 
London 
Task 
150 
– 
widely used 
to 
measure 
executive 
function. 
Created by: Gill DP., Gregory M., Petrella R. M4 Grant Applications 
 
 
 
 
 107 
 
Appendix B. Table 2: Square Stepping Exercise example patterns 
i)         Beginner Pattern – focused on walking-like movements and simple steps 
 
Start 
Walk 
         
Finish 
Walk 
2  4  2  4  
 3  6  3  6 
1  5  1  5  
 
ii)        Intermediate Pattern – incorporates forward, lateral and diagonal movements 
 
Start 
Walk 
3 5 3 5 3 5 3 5  
Finish 
Walk 
1 4 1 4 1 4 1 4 
2 6 2 6 2 6 2 6 
        
 
iii)       Advanced Pattern – a large number of steps per pattern with multiple movement     
types 
 
Start 
Walk 
         
Finish 
Walk 
1 3 7 5 1 3 7 5 
4 2 6 8 4 2 6 8 
        
Created by: Gill DP., Petrella R. M4 Grant Applications 
 
•   Numbers represent consecutive footsteps 
 
• As designed, we will run the SSE in a group format, whereby 5-6 participants 
will be designated to a specific SSE mat. 
 
• Participants will progress as a group to the next step pattern after 80% of 
participants can perform the pattern smoothly. 
 
• For any advanced participants, there are mechanisms by which difficulty can be 
increased within a current pattern (i.e., increasing step speed; avoiding square 
frames, etc.). 
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Appendix C: Statistical Analyses for Chapter 2 
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Correlation Analyses 
 
Correlation between AC and baseline 24-hour ambulatory BP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Correlations 
 x24sbpavg.
0 
x24dbpavg.
0 
x24sbppk.
0 
x24dbppk.
0 
x24map.0 x24hr.0 ac.0 
x24sbpavg
.0 
Pearson Correlation 1 .635** .869** .536** .844** .047 .217 
Sig. (2-tailed)  .000 .000 .000 .000 .670 .051 
N 85 85 85 85 85 85 82 
x24dbpavg
.0 
Pearson Correlation .635** 1 .422** .734** .859** .087 .076 
Sig. (2-tailed) .000  .000 .000 .000 .429 .495 
N 85 85 85 85 85 85 82 
x24sbppk.
0 
Pearson Correlation .869** .422** 1 .444** .740** -.054 .163 
Sig. (2-tailed) .000 .000  .000 .000 .622 .145 
N 85 85 85 85 85 85 82 
x24dbppk.
0 
Pearson Correlation .536** .734** .444** 1 .666** .193 -.017 
Sig. (2-tailed) .000 .000 .000  .000 .076 .881 
N 85 85 85 85 85 85 82 
x24map.0 
Pearson Correlation .844** .859** .740** .666** 1 .053 .157 
Sig. (2-tailed) .000 .000 .000 .000  .628 .158 
N 85 85 85 85 85 85 82 
x24hr.0 
Pearson Correlation .047 .087 -.054 .193 .053 1 -.253* 
Sig. (2-tailed) .670 .429 .622 .076 .628  .022 
N 85 85 85 85 85 85 82 
ac.0 
Pearson Correlation .217 .076 .163 -.017 .157 -.253* 1 
Sig. (2-tailed) .051 .495 .145 .881 .158 .022  
N 82 82 82 82 82 82 85 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Correlation between AC and 6-month ambulatory BP 
 
Correlations 
 x24sbpavg.
1 
x24dbpavg.
1 
x24sbppk.
1 
x24dbppk.
1 
x24map.
1 
x24hr.1 ac.1 
x24sbpavg.
1 
Pearson Correlation 1 .644** .821** .304** .881** -.016 .098 
Sig. (2-tailed)  .000 .000 .010 .000 .895 .424 
N 71 71 71 71 71 71 69 
x24dbpavg.
1 
Pearson Correlation .644** 1 .480** .461** .898** .132 .220 
Sig. (2-tailed) .000  .000 .000 .000 .273 .070 
N 71 71 71 71 71 71 69 
x24sbppk.1 
Pearson Correlation .821** .480** 1 .358** .697** -.085 .201 
Sig. (2-tailed) .000 .000  .002 .000 .481 .097 
N 71 71 71 71 71 71 69 
x24dbppk.1 
Pearson Correlation .304** .461** .358** 1 .389** .030 .124 
Sig. (2-tailed) .010 .000 .002  .001 .806 .312 
N 71 71 71 71 71 71 69 
x24map.1 
Pearson Correlation .881** .898** .697** .389** 1 .035 .199 
Sig. (2-tailed) .000 .000 .000 .001  .772 .102 
N 71 71 71 71 71 71 69 
x24hr.1 
Pearson Correlation -.016 .132 -.085 .030 .035 1 -.458** 
Sig. (2-tailed) .895 .273 .481 .806 .772  .000 
N 71 71 71 71 71 71 69 
ac.1 
Pearson Correlation .098 .220 .201 .124 .199 -.458** 1 
Sig. (2-tailed) .424 .070 .097 .312 .102 .000  
N 69 69 69 69 69 69 72 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Correlation between baseline AC, Age and BMI 
 
Correlations 
 bmi.0 age.0 ac.0 
bmi.0 
Pearson Correlation 1 -.169 .054 
Sig. (2-tailed)  .114 .621 
N 89 89 85 
age.0 
Pearson Correlation -.169 1 -.024 
Sig. (2-tailed) .114  .825 
N 89 89 85 
ac.0 
Pearson Correlation .054 -.024 1 
Sig. (2-tailed) .621 .825  
N 85 85 85 
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Correlation between 6-month AC, and baseline Age and BMI 
 
Correlations 
 age.0 bmi.0 ac.1 
age.0 
Pearson Correlation 1 -.169 -.122 
Sig. (2-tailed)  .114 .307 
N 89 89 72 
bmi.0 
Pearson Correlation -.169 1 .243* 
Sig. (2-tailed) .114  .040 
N 89 89 72 
ac.1 
Pearson Correlation -.122 .243* 1 
Sig. (2-tailed) .307 .040  
N 72 72 72 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Appendix D. Western Health Sciences Research Ethics Board 
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Appendix E. Lawson Health Research Institute Ethics Board 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 115 
 
LAWSON HEALTH RESEARCH INSTITUTE 
FINAL APPROVAL NOTICE 
RESEARCH OFFICE REVIEW NO.: R-12-265 
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Appendix F. Protocol Registration (ClinicalTrials.gov PRS) 
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